Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microtubule binding	MAP2 GOLGA6B GOLGA6A JMY HOOK2 KIF17 MAP7D3 KIF26B GTSE1 NUMA1 GOLGA6C GOLGA6D FSD1 CCDC88A MACF1	1.34e-06	308	215	15	GO:0008017
GeneOntologyMolecularFunction	tubulin binding	MAP2 GOLGA6B GOLGA6A JMY HOOK2 GNAS KIF17 MAP7D3 KIF26B GTSE1 NUMA1 GOLGA6C GOLGA6D FSD1 CCDC88A MACF1	1.72e-05	428	215	16	GO:0015631
GeneOntologyMolecularFunction	cytoskeletal protein binding	MAGI1 MAP2 SPATA31A7 SPTBN2 SYNPO2L OBSCN GOLGA6B GOLGA6A SPATA31A6 SPATA31C1 JMY MYPN HOOK2 GNAS KIF17 SPATA31A3 MAP7D3 KIF26B GTSE1 NUMA1 GOLGA6C GOLGA6D FSD1 SPATA31A5 SLC4A1 CCDC88A SPATA31A1 MACF1	2.05e-05	1099	215	28	GO:0008092
GeneOntologyMolecularFunction	importin-alpha family protein binding	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	6.77e-05	21	215	4	GO:0061676
GeneOntologyBiologicalProcess	Golgi disassembly	GBF1 GOLGA6B GOLGA6A GOLGA6C GOLGA6D	8.81e-07	18	214	5	GO:0090166
GeneOntologyBiologicalProcess	organelle inheritance	GBF1 GOLGA6B GOLGA6A GOLGA6C GOLGA6D	9.28e-06	28	214	5	GO:0048308
GeneOntologyBiologicalProcess	Golgi inheritance	GBF1 GOLGA6B GOLGA6A GOLGA6C GOLGA6D	9.28e-06	28	214	5	GO:0048313
GeneOntologyBiologicalProcess	protein homotetramerization	UPB1 GOLGA6B GOLGA6A ALDH9A1 CRTC3 GOLGA6C GOLGA6D	1.52e-05	77	214	7	GO:0051289
GeneOntologyBiologicalProcess	microtubule polymerization	MAP2 GOLGA6B GOLGA6A MAP7D3 NUMA1 GOLGA6C GOLGA6D INPP5J	3.05e-05	117	214	8	GO:0046785
GeneOntologyBiologicalProcess	positive regulation of protein glycosylation	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.86e-05	19	214	4	GO:0060050
GeneOntologyBiologicalProcess	regulation of glycoprotein biosynthetic process	GATA1 GOLGA6B GOLGA6A ITM2C GOLGA6C GOLGA6D	8.09e-05	69	214	6	GO:0010559
GeneOntologyBiologicalProcess	Golgi ribbon formation	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	8.55e-05	23	214	4	GO:0090161
GeneOntologyBiologicalProcess	regulation of protein glycosylation	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.02e-04	24	214	4	GO:0060049
GeneOntologyBiologicalProcess	supramolecular fiber organization	NEURL2 MAP2 SPTBN2 SYNPO2L OBSCN GOLGA6B GOLGA6A COLGALT2 PTGER4 JMY PIK3R2 MYPN HOOK2 MAP7D3 NUMA1 GOLGA6C GOLGA6D FSD1 TACC2 EMILIN1 CCDC88A MEGF9 INPP5J	1.62e-04	957	214	23	GO:0097435
GeneOntologyBiologicalProcess	Golgi localization	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.64e-04	27	214	4	GO:0051645
GeneOntologyBiologicalProcess	protein tetramerization	UPB1 GOLGA6B GOLGA6A ALDH9A1 CRTC3 GOLGA6C GOLGA6D	1.79e-04	113	214	7	GO:0051262
GeneOntologyBiologicalProcess	regulation of glycoprotein metabolic process	GATA1 GOLGA6B GOLGA6A ITM2C GOLGA6C GOLGA6D	1.84e-04	80	214	6	GO:1903018
GeneOntologyBiologicalProcess	positive regulation of axonogenesis	GOLGA6B GOLGA6A SNAP91 FN1 GOLGA6C GOLGA6D MACF1	1.89e-04	114	214	7	GO:0050772
GeneOntologyBiologicalProcess	meiotic spindle assembly	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.90e-04	28	214	4	GO:0090306
GeneOntologyCellularComponent	nuclear body	PABIR1 SETD1B CCNDBP1 HDAC4 ACD CDK12 OBSCN SRCAP SBF1 SAP130 KLF11 CENPT PHC1 RFWD3 PPP1R8 BAZ2A HSPB6 MDC1 SETBP1 ACIN1 YY1AP1 N4BP1 MAPK7 SRRM2 SON	8.18e-06	903	217	25	GO:0016604
GeneOntologyCellularComponent	coated vesicle	GOLGA6B GOLGA6A SNAP91 PIK3C2A SEC16A AP1G2 GNAS COL7A1 TEPSIN GOLGA6C GOLGA6D AP3B1 CCDC88A	1.06e-04	360	217	13	GO:0030135
GeneOntologyCellularComponent	COPI-coated Golgi to ER transport vesicle	GNAS CCDC88A	1.07e-04	2	217	2	GO:0030142
GeneOntologyCellularComponent	AP-type membrane coat adaptor complex	SNAP91 AP1G2 TEPSIN AP3B1 LRRN3	1.37e-04	48	217	5	GO:0030119
GeneOntologyCellularComponent	clathrin adaptor complex	SNAP91 AP1G2 AP3B1 LRRN3	2.85e-04	31	217	4	GO:0030131
GeneOntologyCellularComponent	ciliary neurotrophic factor receptor complex	CNTFR IL6R	3.20e-04	3	217	2	GO:0070110
GeneOntologyCellularComponent	Golgi cis cisterna	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.65e-04	33	217	4	GO:0000137
MousePheno	increased alveolar macrophage number	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.20e-05	14	176	4	MP:0014228
MousePheno	absent sperm mitochondrial sheath	GOLGA6B GOLGA6A ACTL7B GOLGA6C GOLGA6D	2.32e-05	28	176	5	MP:0009833
MousePheno	abnormal alveolar macrophage number	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.97e-05	15	176	4	MP:0014227
MousePheno	slow postnatal weight gain	GOLGA6B GOLGA6A ATXN1 GNAS COL7A1 RHBDF1 GOLGA6C GOLGA6D SLC4A1 HELZ2 SON	5.72e-05	205	176	11	MP:0008489
Domain	DUF4599	SPATA31A7 SPATA31A6 SPATA31C1 SPATA31A3 SPATA31C2 SPATA31A5	1.89e-09	12	215	6	PF15371
Domain	DUF4599	SPATA31A7 SPATA31A6 SPATA31C1 SPATA31A3 SPATA31C2 SPATA31A5	1.89e-09	12	215	6	IPR027970
Domain	FN3	EPHB6 INSRR OBSCN CNTFR LRIT2 COL7A1 FN1 COL20A1 FSD1 LRRN3 TRIM9 OSMR HCFC1 IL6R	3.17e-08	185	215	14	SM00060
Domain	FN3	EPHB6 INSRR OBSCN CNTFR LRIT2 COL7A1 FN1 COL20A1 FSD1 LRRN3 TRIM9 OSMR HCFC1 IL6R	7.92e-08	199	215	14	PS50853
Domain	FN3_dom	EPHB6 INSRR OBSCN CNTFR LRIT2 COL7A1 FN1 COL20A1 FSD1 LRRN3 TRIM9 OSMR HCFC1 IL6R	1.45e-07	209	215	14	IPR003961
Domain	fn3	EPHB6 INSRR OBSCN CNTFR COL7A1 FN1 COL20A1 FSD1 LRRN3 TRIM9 OSMR IL6R	3.94e-07	162	215	12	PF00041
Domain	GOLGA2L5	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.60e-05	18	215	4	PF15070
Domain	Golgin_A	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.60e-05	18	215	4	IPR024858
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A7 SPATA31A6 SPATA31C1 SPATA31A3 SPATA31A5 SPATA31A1	5.98e-14	6	220	6	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A7 SPATA31A6 SPATA31C1 SPATA31A3 SPATA31A5 SPATA31A1	5.98e-14	6	220	6	25930072
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PABIR1 MAGI1 HIVEP2 GBF1 HDAC4 MAP2 MEX3C SBF1 PIK3C2A ATXN1 PRRC2C PI4KA SEC16A GNAS CRTC3 MAP7D3 KIF26B GTSE1 FSD1 HDAC7 CCDC88A DCP1B TRIM9 MACF1 SRRM2 PCDH7 SH3RF3 CEP170B OTOG	2.62e-13	861	220	29	36931259
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HIVEP2 GBF1 SETD1B MFHAS1 PPRC1 CDK12 OBSCN PER1 ZFPM1 SRCAP MBD6 SBF1 PI4KA MCM3AP SEC16A AP1G2 WNK2 DGCR2 RHBDF1 ZNF628 POLG GTSE1 LAMB2 FBXO46 HDAC7 HELZ2 HMGXB3 HCFC1 CEP170B ARHGAP33 TJP3	4.24e-12	1105	220	31	35748872
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	PABIR1 ACD TICAM1 PER1 WDR81 POGZ NR4A1 LRCH1 MEX3C MCM3AP MYPN SEC16A AP1G2 HOOK2 GNAS CNOT3 CRTC3 TEPSIN RPAP3 GTSE1 AP3B1 RFWD3 CCDC88A DCP1B WDCP MAPK7 PPP6R2 TJP3	1.25e-10	1038	220	28	26673895
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETD1B PPRC1 POGZ GPATCH8 SNX19 PRRC2C MCM3AP SEC16A KIF17 HEATR5A MEGF9 BAZ2A ACIN1 MACF1 YY1AP1 SRRM2 CEP170B SON	1.51e-10	407	220	18	12693553
Pubmed	A human MAP kinase interactome.	MAGI1 HIVEP2 HDAC4 SPTBN2 POGZ TOX4 ATXN1 PIK3R2 MCM3AP WNK2 CRTC3 KIF26B ITSN1 LAMB2 CCDC88A MACF1 YY1AP1 MAPK7 ARHGAP33	3.64e-10	486	220	19	20936779
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	GBF1 CDK12 POGZ ZFPM1 GPATCH8 ADARB1 SEC16A TAF6 CNOT3 ITSN1 GTSE1 PHRF1 NUMA1 HDAC7 BAZ2A MDC1 HELZ2 ACIN1 YY1AP1 SRRM2 PCDH7 SON	5.38e-09	774	220	22	15302935
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	SP2 TGIF2 HIVEP2 VEZF1 TRIM35 GATA1 NPAS3 POGZ NR4A1 MEX3C TOX4 KLF11 TACC2 ZNF692 PHC1 BCL11B ZNF532 BAZ2A TRIM9 MACF1 HMGXB3	5.99e-09	709	220	21	22988430
Pubmed	Ectopic clustering of Cajal-Retzius and subplate cells is an initial pathological feature in Pomgnt2-knockout mice, a model of dystroglycanopathy.	MAP2 GOLGA6B GOLGA6A GOLGA6C GOLGA6D BCL11B	7.32e-09	24	220	6	26060116
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A7 SPATA31A6 SPATA31C1 SPATA31A3 SPATA31A5 SPATA31A1	7.32e-09	24	220	6	32212159
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CAND2 CDK12 TRIM35 NACA POGZ LRCH1 SBF1 WNK2 DGCR2 PHRF1 CCDC88A ZNF532 TRIM9 MDC1 SETBP1 SDC3 HMGXB3 EIF2AK4	9.37e-09	529	220	18	14621295
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	GBF1 HDAC4 PIK3R2 BUB1 SAP130 WNK2 CRTC3 ITSN1 GTSE1 NUMA1 FSD1 ZNF532 MDC1 SETBP1 ZMYM5 SON	1.87e-08	430	220	16	35044719
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	POGZ SRCAP TOX4 MCM3AP GNL2 TRMT1L SAP130 SBNO1 BAZ2A MDC1 ACIN1 YY1AP1 SRRM2 HCFC1	4.43e-08	341	220	14	32971831
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	PER1 POGZ SRCAP TRIM66 ATXN1 PIK3R2 MCM3AP SEC16A GNL2 ITM2C TAF6 SAP130 BTBD18 PHRF1 SLC4A1 TTC7A BCL11B BAZ2A MACF1 SIGLEC1 OSMR SRRM2 CEP170B ARHGAP33 SON	5.13e-08	1116	220	25	31753913
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MAGI1 HDAC4 SPTBN2 WDR81 GOLGA6B GOLGA6A SBF1 SNAP91 PRRC2C PI4KA SEC16A PPP1R3F WNK2 PRR36 ITSN1 NUMA1 GOLGA6C GOLGA6D BCL11B CCDC88A MACF1 PPP6R2 CEP170B	5.84e-08	963	220	23	28671696
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	CDK12 SPTBN2 POGZ SRCAP TOX4 PRRC2C SEC16A TAF6 SAP130 MAP7D3 RPAP3 NUMA1 AP3B1 BAZ2A MDC1 ACIN1 HCFC1	9.49e-08	549	220	17	38280479
Pubmed	Human transcription factor protein interaction networks.	SP2 VEZF1 NACA GATA1 POGZ GPATCH8 SRCAP MBD6 ATXN1 PRRC2C SEC16A GNL2 TRMT1L TAF6 SAP130 CNOT3 TANGO6 NUMA1 PROSER1 DCP1B TRIM9 WDCP MDC1 YY1AP1 N4BP1 SRRM2 PCDH7 HCFC1	1.25e-07	1429	220	28	35140242
Pubmed	TMED2/emp24 is required in both the chorion and the allantois for placental labyrinth layer development.	GOLGA6B GOLGA6A FN1 GOLGA6C GOLGA6D	1.39e-07	20	220	5	30236446
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SPTBN2 POGZ SBF1 PRRC2C MCM3AP SEC16A GNL2 FN1 PHRF1 NUMA1 BAZ2A MDC1 HELZ2 ACIN1 MACF1 SRRM2 HCFC1 SON	2.21e-07	653	220	18	22586326
Pubmed	Anagrelide represses GATA-1 and FOG-1 expression without interfering with thrombopoietin receptor signal transduction.	PDE3A GATA1 ZFPM1	2.50e-07	3	220	3	20586925
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	SETD1B SRCAP PRRC2C PI4KA MCM3AP BUB1 SEC16A GNAS CNOT3 ITSN1 TACC2 CCDC88A WDCP MACF1 YY1AP1 PPP6R2 CEP170B	2.50e-07	588	220	17	38580884
Pubmed	ADP Ribosylation Factor 4 (Arf4) Regulates Radial Migration through N-Cadherin Trafficking during Cerebral Cortical Development.	MAP2 GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.97e-07	23	220	5	37848288
Pubmed	Reelin and stk25 have opposing roles in neuronal polarization and dendritic Golgi deployment.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D BCL11B	2.97e-07	23	220	5	21111240
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	SALL3 POGZ GPATCH8 TAF6 NUMA1 BCL11B BAZ2A ACIN1	3.20e-07	103	220	8	32744500
Pubmed	Brain development is impaired in c-fos -/- mice.	MAP2 GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.64e-07	25	220	5	26143639
Pubmed	CDK5RAP2 expression during murine and human brain development correlates with pathology in primary autosomal recessive microcephaly.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D BCL11B	5.71e-07	26	220	5	22806269
Pubmed	Wnt11 directs nephron progenitor polarity and motile behavior ultimately determining nephron endowment.	GOLGA6B GOLGA6A FN1 GOLGA6C GOLGA6D	6.97e-07	27	220	5	30516471
Pubmed	Neural crest cells utilize primary cilia to regulate ventral forebrain morphogenesis via Hedgehog-dependent regulation of oriented cell division.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D SMO	8.45e-07	28	220	5	28941984
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	SALL3 VEZF1 CDK12 POGZ TOX4 SNAP91 PRRC2C SEC16A GNL2 TAF6 SAP130 CENPT MAP7D3 GTSE1 NUMA1 BAZ2A MDC1 ACIN1 SRRM2 HCFC1 SON	8.48e-07	954	220	21	36373674
Pubmed	Transcriptional corepressors HIPK1 and HIPK2 control angiogenesis via TGF-β-TAK1-dependent mechanism.	EPO PPRC1 GATA1 IER3 HDAC7	1.02e-06	29	220	5	23565059
Pubmed	Globozoospermia and lack of acrosome formation in GM130-deficient mice.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.07e-06	13	220	4	28055014
Pubmed	GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.07e-06	13	220	4	33740186
Pubmed	Loss of GM130 does not impair oocyte meiosis and embryo development in mice.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.07e-06	13	220	4	32873390
Pubmed	GM130, a cis-Golgi protein, regulates meiotic spindle assembly and asymmetric division in mouse oocyte.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.07e-06	13	220	4	21552007
Pubmed	Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.07e-06	13	220	4	28028212
Pubmed	GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.07e-06	13	220	4	29128360
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SP2 TGIF2 CDX2 SALL3 VEZF1 GATA1 POGZ SRCAP ZDHHC1 TOX4 ATXN1 TAF6 NPAS2 KLF11 PHC1 BAZ2A ACIN1 HMGXB3 ZMYM5	1.10e-06	808	220	19	20412781
Pubmed	Adamtsl2 deletion results in bronchial fibrillin microfibril accumulation and bronchial epithelial dysplasia--a novel mouse model providing insights into geleophysic dysplasia.	GOLGA6B GOLGA6A FN1 GOLGA6C GOLGA6D	1.44e-06	31	220	5	25762570
Pubmed	Cdk1 protects against oxygen-glucose deprivation and reperfusion-induced Golgi fragmentation and apoptosis through mediating GM130 phosphorylation.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.48e-06	14	220	4	37831422
Pubmed	GM130 and p115 play a key role in the organisation of the early secretory pathway during skeletal muscle differentiation.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.48e-06	14	220	4	30630895
Pubmed	Golgb1 regulates protein glycosylation and is crucial for mammalian palate development.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.48e-06	14	220	4	27226319
Pubmed	Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.48e-06	14	220	4	33543287
Pubmed	The giant spectrin βV couples the molecular motors to phototransduction and Usher syndrome type I proteins along their trafficking route.	SPTBN2 GOLGA6B GOLGA6A GOLGA6C GOLGA6D	1.70e-06	32	220	5	23704327
Pubmed	Golgi disruption and early embryonic lethality in mice lacking USO1.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.01e-06	15	220	4	23185636
Pubmed	The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.01e-06	15	220	4	17046993
Pubmed	Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.01e-06	15	220	4	17189423
Pubmed	WDR38, a novel equatorial segment protein, interacts with the GTPase protein RAB19 and Golgi protein GM130 to play roles in acrosome biogenesis.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.01e-06	15	220	4	37635409
Pubmed	Golga5 is dispensable for mouse embryonic development and postnatal survival.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.01e-06	15	220	4	28509431
Pubmed	GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.01e-06	15	220	4	26165940
Pubmed	Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.01e-06	15	220	4	17204322
Pubmed	Demonstration of the expression and the enzymatic activity of N-acetylglucosaminyltransferase IX in the mouse brain.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.01e-06	15	220	4	16413118
Pubmed	RhoA-mediated FMNL1 regulates GM130 for actin assembly and phosphorylates MAPK for spindle formation in mouse oocyte meiosis.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.01e-06	15	220	4	26083584
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	GBF1 VEZF1 CDK12 SPTBN2 NACA POGZ MEX3C TOX4 PIK3C2A PRRC2C MCM3AP EHD1 SEC16A GNL2 GNAS AIMP2 FN1 NUMA1 AP3B1 FBXO46 HELZ2 ACIN1 EIF2AK4 HCFC1 SON	2.26e-06	1371	220	25	36244648
Pubmed	The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.	GOLGA6B GOLGA6A SBF1 PIK3C2A PI4KA SEC16A GTSE1 GOLGA6C GOLGA6D EIF2AK4	2.33e-06	230	220	10	35449600
Pubmed	LIM kinase 2 is widely expressed in all tissues.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.67e-06	16	220	4	16399995
Pubmed	SLC24A5 encodes a trans-Golgi network protein with potassium-dependent sodium-calcium exchange activity that regulates human epidermal melanogenesis.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.67e-06	16	220	4	18166528
Pubmed	Molecular motor KIF1C is not essential for mouse survival and motor-dependent retrograde Golgi apparatus-to-endoplasmic reticulum transport.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.67e-06	16	220	4	11784862
Pubmed	p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.67e-06	16	220	4	21640725
Pubmed	Molecular characterization of mitocalcin, a novel mitochondrial Ca2+-binding protein with EF-hand and coiled-coil domains.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	2.67e-06	16	220	4	16336229
Pubmed	Dynamics and function of CXCR4 in formation of the granule cell layer during hippocampal development.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.48e-06	17	220	4	28717168
Pubmed	The Protein Tyrosine Phosphatase MEG2 Regulates the Transport and Signal Transduction of Tropomyosin Receptor Kinase A.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.48e-06	17	220	4	27655914
Pubmed	Vesicle budding from endoplasmic reticulum is involved in calsequestrin routing to sarcoplasmic reticulum of skeletal muscles.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.48e-06	17	220	4	14728599
Pubmed	Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.48e-06	17	220	4	14718562
Pubmed	A truncating mutation of TRAPPC9 is associated with autosomal-recessive intellectual disability and postnatal microcephaly.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	3.48e-06	17	220	4	20004763
Pubmed	Morphogenesis of the mouse neural plate depends on distinct roles of cofilin 1 in apical and basal epithelial domains.	GOLGA6B GOLGA6A FN1 GOLGA6C GOLGA6D	3.58e-06	37	220	5	25742799
Pubmed	p115 Interacts with the GLUT4 vesicle protein, IRAP, and plays a critical role in insulin-stimulated GLUT4 translocation.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.45e-06	18	220	4	15800058
Pubmed	Altered GLUT4 trafficking in adipocytes in the absence of the GTPase Arfrp1.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.45e-06	18	220	4	20230794
Pubmed	Yip1B isoform is localized at ER-Golgi intermediate and cis-Golgi compartments and is not required for maintenance of the Golgi structure in skeletal muscle.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.45e-06	18	220	4	25208654
Pubmed	Notch inhibition by the ligand DELTA-LIKE 3 defines the mechanism of abnormal vertebral segmentation in spondylocostal dysostosis.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.45e-06	18	220	4	21147753
Pubmed	N-cadherin sustains motility and polarity of future cortical interneurons during tangential migration.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.45e-06	18	220	4	24227724
Pubmed	Flightless, secreted through a late endosome/lysosome pathway, binds LPS and dampens cytokine secretion.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.45e-06	18	220	4	22718342
Pubmed	Expression, localization, and biochemical characterization of nicotinamide mononucleotide adenylyltransferase 2.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.45e-06	18	220	4	20943658
Pubmed	Protein kinase LKB1 regulates polarized dendrite formation of adult hippocampal newborn neurons.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	4.45e-06	18	220	4	24367100
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	CDK12 NACA COLGALT2 SBF1 PRRC2C BUB1 HOOK2 RPAP3 AP3B1 RFWD3 CCDC88A WDCP YY1AP1 EIF2AK4 PPP6R2 HCFC1	4.51e-06	650	220	16	38777146
Pubmed	Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse.	GOLGA6B GOLGA6A FN1 GOLGA6C GOLGA6D	4.68e-06	39	220	5	21606205
Pubmed	Fibrillin-2 is a key mediator of smooth muscle extracellular matrix homeostasis during mouse tracheal tubulogenesis.	GOLGA6B GOLGA6A FN1 GOLGA6C GOLGA6D	5.32e-06	40	220	5	30578393
Pubmed	Cell influx and contractile actomyosin force drive mammary bud growth and invagination.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.60e-06	19	220	4	34042944
Pubmed	Presenilin 1 mediates the turnover of telencephalin in hippocampal neurons via an autophagic degradative pathway.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.60e-06	19	220	4	15452145
Pubmed	Scrg1, a novel protein of the CNS is targeted to the large dense-core vesicles in neuronal cells.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.60e-06	19	220	4	14622145
Pubmed	Deletion of IFT20 exclusively in the RPE ablates primary cilia and leads to retinal degeneration.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.60e-06	19	220	4	38048369
Pubmed	Pilt is a coiled-coil domain-containing protein that localizes at the trans-Golgi complex and regulates its structure.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.60e-06	19	220	4	22841714
Pubmed	SDF2L1 interacts with the ER-associated degradation machinery and retards the degradation of mutant proinsulin in pancreatic β-cells.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.60e-06	19	220	4	23444373
Pubmed	Presenilin 1 and presenilin 2 have differential effects on the stability and maturation of nicastrin in Mammalian brain.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.60e-06	19	220	4	12646573
Pubmed	CLASP2 safeguards hematopoietic stem cell properties during mouse and fish development.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.60e-06	19	220	4	35705037
Pubmed	Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.60e-06	19	220	4	17664336
Pubmed	Spatial regulation of Raf kinase signaling by RKTG.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.60e-06	19	220	4	17724343
Pubmed	Stage-dependent function of Wnt5a during male external genitalia development.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.60e-06	19	220	4	34255394
Pubmed	Regulation of amino acid transporter ATA2 by ubiquitin ligase Nedd4-2.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	5.60e-06	19	220	4	17003038
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	NACA PRRC2C MYPN SEC16A MAP7D3 RPAP3 KIF26B GTSE1 CCDC88A HCFC1	6.03e-06	256	220	10	33397691
Pubmed	Rbx2 regulates neuronal migration through different cullin 5-RING ligase adaptors.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D BCL11B	6.80e-06	42	220	5	24210661
Pubmed	Furin is the primary in vivo convertase of angiopoietin-like 3 and endothelial lipase in hepatocytes.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	6.97e-06	20	220	4	23918928
Pubmed	The COPI vesicle complex binds and moves with survival motor neuron within axons.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	6.97e-06	20	220	4	21300694
Pubmed	Development of the post-natal growth plate requires intraflagellar transport proteins.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	6.97e-06	20	220	4	17359961
Pubmed	The molecular complex of ciliary and golgin protein is crucial for skull development.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	6.97e-06	20	220	4	34128978
Pubmed	Overlapping Role of SCYL1 and SCYL3 in Maintaining Motor Neuron Viability.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	6.97e-06	20	220	4	29437892
Pubmed	Intraflagellar transport molecules in ciliary and nonciliary cells of the retina.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	6.97e-06	20	220	4	20368623
Pubmed	Maximizing the ovarian reserve in mice by evading LINE-1 genotoxicity.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	6.97e-06	20	220	4	31949138
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	SETD1B HDAC4 SRCAP MBD6 HDAC7 PHC1 BCL11B BAZ2A	7.69e-06	157	220	8	30186101
Pubmed	Canonical and noncanonical intraflagellar transport regulates craniofacial skeletal development.	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	8.57e-06	21	220	4	27118846
Interaction	YWHAE interactions	PABIR1 HIVEP2 GBF1 HDAC4 ACD CDK12 MBD6 LRCH1 MEX3C SBF1 PIK3C2A ATXN1 PIK3R2 SAP130 WNK2 CRTC3 AIMP2 FN1 MAP7D3 RPAP3 KIF26B GTSE1 TACC2 HDAC7 CCDC88A DCP1B MACF1 MAPK7 SRRM2 PCDH7 SH3RF3 CEP170B ARHGAP33 OTOG	5.56e-07	1256	216	34	int:YWHAE
Interaction	NUP43 interactions	SETD1B CDK12 POGZ GPATCH8 SRCAP PRRC2C PI4KA MCM3AP GNL2 TRMT1L TAF6 CENPT PHRF1 CCDC88A ZNF532 BAZ2A MDC1 ACIN1 SRRM2 PPP6R2 HCFC1 SON	1.09e-06	625	216	22	int:NUP43
Interaction	YWHAG interactions	PABIR1 MAGI1 HIVEP2 GBF1 HDAC4 MAP2 CDK12 SBF1 PIK3C2A ATXN1 PRRC2C PI4KA SEC16A GNAS CRTC3 FN1 MAP7D3 RPAP3 KIF26B GTSE1 HDAC7 CCDC88A DCP1B HSPB6 ACIN1 MACF1 MAPK7 SRRM2 PCDH7 SH3RF3 CEP170B OTOG SON	1.40e-06	1248	216	33	int:YWHAG
Interaction	TOP3B interactions	HIVEP2 GBF1 SETD1B HDAC4 MFHAS1 PPRC1 CDK12 SPTBN2 OBSCN PER1 ZFPM1 SRCAP MBD6 SBF1 PI4KA MCM3AP SEC16A AP1G2 GNAS WNK2 DGCR2 RHBDF1 ZNF628 POLG GTSE1 LAMB2 FBXO46 HDAC7 MDC1 HELZ2 ACIN1 HMGXB3 HCFC1 CEP170B ARHGAP33 TJP3	2.59e-06	1470	216	36	int:TOP3B
Interaction	YWHAH interactions	PABIR1 MAGI1 HIVEP2 GBF1 HDAC4 MAP2 MEX3C SBF1 PIK3C2A ATXN1 PRRC2C PI4KA SEC16A WNK2 CRTC3 FN1 MAP7D3 KIF26B GTSE1 FSD1 HDAC7 CCDC88A DCP1B MACF1 MAPK7 SRRM2 SH3RF3 CEP170B OTOG	7.19e-06	1102	216	29	int:YWHAH
Interaction	CLRN3 interactions	GOLGA6B GOLGA6A GOLGA6C GOLGA6D	8.51e-06	13	216	4	int:CLRN3
Interaction	NPTXR interactions	HDAC4 HOOK2 FN1 PHC1 NPTXR	9.00e-06	27	216	5	int:NPTXR
Interaction	YWHAZ interactions	PABIR1 HIVEP2 GBF1 HDAC4 MAP2 SPTBN2 NR4A1 LRCH1 SBF1 PIK3C2A ATXN1 PIK3R2 ALDH9A1 WNK2 KLF11 CRTC3 AIMP2 FN1 MAP7D3 KIF26B TACC2 AP3B1 HDAC7 CCDC88A DCP1B HSPB6 MDC1 MACF1 MAPK7 PCDH7 CEP170B OTOG	1.22e-05	1319	216	32	int:YWHAZ
Interaction	CLTB interactions	OBSCN PIK3C2A ATXN1 SEC16A FN1 ITSN1 GTSE1 ARX AP3B1 DCP1B	3.22e-05	185	216	10	int:CLTB
Interaction	TLE3 interactions	HIVEP2 VEZF1 CDK12 GATA1 GPATCH8 ATXN1 MCM3AP SAP130 CRTC3 PROSER1 BCL11B WDCP SRRM2 SON	5.81e-05	376	216	14	int:TLE3
Interaction	SFN interactions	MKRN3 PABIR1 MAGI1 GBF1 HDAC4 MAP2 PIK3C2A ATXN1 PRRC2C SAP130 CRTC3 MAP7D3 RPAP3 KIF26B HDAC7 CCDC88A MACF1 SRRM2 PCDH7 CEP170B	5.89e-05	692	216	20	int:SFN
Cytoband	11q13	SPTBN2 EHD1 CD248 NUMA1 KCNK7 BSCL2	2.38e-05	118	220	6	11q13
GeneFamily	Fibronectin type III domain containing	EPHB6 INSRR OBSCN CNTFR COL7A1 FN1 COL20A1 FSD1 LRRN3 TRIM9 OSMR	4.35e-08	160	139	11	555
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	WDR81 PPP1R3F PHRF1 PPP1R8 TMEM132D HSPB6 PCDH7 HCFC1 HYDIN	1.11e-05	181	139	9	694
GeneFamily	Histone deacetylases, class IIA	HDAC4 HDAC7	3.49e-04	4	139	2	992
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	OBSCN MYPN ADGRA3 LRIT2 LRRN3 SIGLEC1	1.54e-03	161	139	6	593
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	TGIF2 NACA POGZ PRRC2C PI4KA PRRT3 SEC16A RHBDF1 PRR36 MEGF9 BAZ2A SRRM2 INPP5J TJP3	4.71e-06	385	218	14	M2840
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	UPB1 PPRC1 TICAM1 SRCAP CNOT3 TEPSIN ZNF692 FBXO46 HDAC7 ACIN1 SRRM2 PPP6R2 HCFC1	5.68e-06	338	218	13	M17094
Coexpression	GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_UP	EPHB6 SETD1B PER1 SRCAP LRCH1 HERC2P3 TRIM66 DGCR2 ACIN1 PCDH7	7.01e-06	199	218	10	M8301
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDE3A ADGRA3 NPAS2 COL7A1 FN1 TACC2 ZNF385D TRIM9 OSMR SH3RF3	2.62e-08	182	220	10	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	LINC00311 COLGALT2 SNX19 CENPT NBPF11 MDC1 ZMYM5 ARHGAP33	7.93e-07	149	220	8	a34d095b8e0fe59d69d84e4fd2fe4ccb82f92e4f
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYPN ADGRA3 FN1 CD248 PI16 KIF26B EIF2AK4 HYDIN	1.49e-06	162	220	8	56f1789e69a6cb29956e46aba92b290847327c1f
ToppCell	Adult-Epithelial-lung_goblet_cell-D175\|Adult / Lineage, Cell type, age group and donor	SPTBN2 NR4A1 FER1L6 WNK2 KIF26B MUC16 ERN2 PCDH7	1.63e-06	164	220	8	6e6aedb61f8e195d52e028fdda750a29bb14e57e
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EXD1 BEST3 FER1L6 RFX4 SLC4A1 TFR2 BCL11B TMEM132D	2.23e-06	171	220	8	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	MAGI1 PDE3A OBSCN GOLGA6B MYPN HOOK2 TACC2 PCDH7	3.84e-06	184	220	8	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	MAGI1 PDE3A OBSCN SNAP91 HOOK2 WNK2 TACC2 PCDH7	4.69e-06	189	220	8	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	MAGI1 PDE3A OBSCN MYPN HOOK2 WNK2 TACC2 PCDH7	5.06e-06	191	220	8	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COLGALT2 CNTFR CD248 PI16 EMILIN1 ZNF385D SETBP1 PCDH7	5.26e-06	192	220	8	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	MAP2 ADARB1 FN1 KIF26B EMILIN1 LRRN3 MACF1 PCDH7	5.26e-06	192	220	8	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	HIVEP2 PPRC1 PER1 NR4A1 PIK3C2A IER3 HELZ2 YY1AP1	5.47e-06	193	220	8	dbf0fe496254320c894568c31e5f9ce63707d1b5
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INSRR PRRC2C VPS13A SEC16A MACF1 SRRM2 IL6R SON	5.90e-06	195	220	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INSRR PRRC2C VPS13A SEC16A MACF1 SRRM2 IL6R SON	5.90e-06	195	220	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	PCW_05-06-Mesenchymal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	PDE3A CNTFR FN1 CD248 EMILIN1 ZNF385D SETBP1 PCDH7	6.12e-06	196	220	8	dca52c57ba35d9395cdbca8b881f12ece721b10f
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	CERKL MEX3C SEC16A NPAS2 NPTXR SETBP1 MACF1 N4BP1	6.59e-06	198	220	8	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	Fetal_29-31_weeks\|World / Lineage, Cell type, age group and donor	NR4A1 ITM2C ADGRA3 FN1 KIF26B EMILIN1 ZNF385D PCDH7	6.84e-06	199	220	8	5b9d355795dd03a22f0961dfd143425c367a4654
ToppCell	Bronchial-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A NPAS3 COLGALT2 ADGRA3 CNTFR FN1 ZNF385D TRIM9	7.10e-06	200	220	8	b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	CNOT3 RPAP3 GTSE1 ARX AP3B1 DCP1B RELT ARHGAP33	7.10e-06	200	220	8	4e077aa7faddcebdfc54667f8b3990704441005b
ToppCell	Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A NPAS3 COLGALT2 ADGRA3 CNTFR FN1 ZNF385D TRIM9	7.10e-06	200	220	8	7c673ad0ea503ebd196579684d25d5f9e6a41030
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	CNOT3 RPAP3 GTSE1 ARX AP3B1 DCP1B RELT ARHGAP33	7.10e-06	200	220	8	d17ba4239e1fd702a3d757687110f0f2c6f91ef7
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SNAP91 MYPN BUB1 DMBT1 WNK2 SIGLEC1 HYDIN	1.63e-05	162	220	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HGFAC GATA1 MS4A2 IER3 SH2D7 PCDHB13 TFR2	2.58e-05	174	220	7	e9e4532a474b4b0938a50ff85c9508aca53cd3ae
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GARIN1A TDRD10 CD248 EMILIN1 LRRN3 PCDH7 SH3RF3	2.78e-05	176	220	7	b4a23d8d1414434adeb237a96f28c825f1aebd77
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GARIN1A TDRD10 CD248 EMILIN1 LRRN3 PCDH7 SH3RF3	2.78e-05	176	220	7	66c9c6b59030f67e8d746a9c6930e50923f2ded1
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRSS22 NR4A1 FER1L6 WNK2 MUC16 ERN2 MACF1	3.09e-05	179	220	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADGRG4 EXD3 ITM2C DMBT1 WNK2 CNTFR TJP3	3.21e-05	180	220	7	7c7c4d64ff99d0710a7d19d8bc29fc9217394db1
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE3A CDX2 ADGRG4 EXD3 ITM2C DMBT1 CNTFR	3.21e-05	180	220	7	b234668bf181522807470e396792e1b54890b719
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4\|TCGA-Thryoid / Sample_Type by Project: Shred V9	MAP2 SPTBN2 RHBDF1 FN1 MEGF9 NPTXR CEP170B	3.69e-05	184	220	7	d9659d1e4465fec68f48a22edef443f354f6c7cf
ToppCell	droplet-Spleen-nan-21m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATA1 CLCA1 CD248 GTSE1 TFR2 SMO PCDH7	3.82e-05	185	220	7	239cc5184825b3cc98638d4aec0a1de8e508d76c
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	MAGI1 PDE3A OBSCN MYPN HOOK2 TACC2 PCDH7	3.82e-05	185	220	7	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	systemic_lupus_erythematosus-managed-Hematopoietic-Progen-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EPHB6 GATA1 MS4A2 ADGRA3 ZNF385D LRRN3 BCL11B	3.82e-05	185	220	7	a139e95d31af9866ed2d4618ad67557851b98ef3
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	MAGI1 PDE3A OBSCN MYPN HOOK2 TACC2 PCDH7	4.37e-05	189	220	7	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 SPTBN2 INSRR NR4A1 NPAP1 SLC4A1 INPP5J	4.37e-05	189	220	7	a9864873b19ab3e60acf11f288fa7275badc2e42
ToppCell	SupraBC-Differ-KC\|World / shred by cell class for mouse tongue	EPHB6 MAGI1 MAP2 SPTBN2 PNPLA1 SDC3 PCDH1	4.37e-05	189	220	7	6412741b88e241304033b41effca0c77a374d907
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CERKL PTGER4 JMY ATXN1 BCL11B MACF1 N4BP1	4.52e-05	190	220	7	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A ADARB1 NPAS2 KIF26B EMILIN1 OSMR PCDH7	4.52e-05	190	220	7	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	facs-Tongue-nan-3m-Epithelial-suprabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB6 MAGI1 MAP2 SPTBN2 PNPLA1 SDC3 PCDH1	4.52e-05	190	220	7	719a5cecc3e8001ca9c38165258b5ff9c800713a
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	MAGI1 BEST3 GNAS ARX ZNF385D LRRN3 CCDC88A	4.52e-05	190	220	7	842760bfe0a52e67bad800efa7d99448a4a23ebb
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	MAGI1 PDE3A OBSCN HOOK2 WNK2 TACC2 PCDH7	4.52e-05	190	220	7	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	PRRC2C VPS13A GTSE1 LAMB2 CCDC88A SRRM2 SON	4.83e-05	192	220	7	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	MAGI1 OBSCN MYPN HOOK2 WNK2 TACC2 PCDH7	4.83e-05	192	220	7	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A ADARB1 KIF26B EMILIN1 SETBP1 OSMR PCDH7	4.83e-05	192	220	7	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE3A MYPN ITM2C CNTFR KIF26B TMEM132D PCDH7	4.99e-05	193	220	7	4ccf984baebbb13ae916727137ce593fda7514a2
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	PDE3A OBSCN MYPN NPAS2 TACC2 DCP1B PCDH7	4.99e-05	193	220	7	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE3A MYPN ITM2C CNTFR KIF26B TMEM132D PCDH7	4.99e-05	193	220	7	f27e2be497745098b5269aa799dd3d5f62d78ba7
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PDE3A COLGALT2 CNTFR CD248 PI16 ZNF385D SETBP1	4.99e-05	193	220	7	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	ADARB1 COL7A1 FN1 EMILIN1 LRRN3 MACF1 PCDH7	4.99e-05	193	220	7	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	PER1 PTGER4 PRRC2C GNAS HELZ2 N4BP1 SRRM2	4.99e-05	193	220	7	7256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell	PND01\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PER1 CLCA1 IER3 FN1 MACF1 IL6R ZMYM5	4.99e-05	193	220	7	c291345c11cfcbceacbdc001a5851f67478a2779
ToppCell	cellseq-Epithelial-Epithelial_Glandular\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRSS22 FER1L6 DMBT1 WNK2 MUC16 ERN2 MUC7	5.16e-05	194	220	7	d0fb1ff5cf0738881e114a58f0b27489f781d72b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A ADARB1 KIF26B EMILIN1 SETBP1 OSMR PCDH7	5.16e-05	194	220	7	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	MAGI1 PDE3A OBSCN MYPN WNK2 TACC2 PCDH7	5.33e-05	195	220	7	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	PTGER4 ADARB1 ALDH9A1 FN1 EMILIN1 LRRN3 MACF1	5.50e-05	196	220	7	6730743cf088c419ccc2d28765769fc09d3ba6a7
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	PTGER4 ADARB1 ALDH9A1 FN1 EMILIN1 LRRN3 MACF1	5.50e-05	196	220	7	21dab89f3699037138a9c7a0e4dc98739a9fad9c
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPTBN2 PRSS22 FER1L6 MUC16 PCDH1 HYDIN TJP3	5.68e-05	197	220	7	5c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADARB1 ADGRG4 FN1 PI16 EMILIN1 ZNF385D SH3RF3	5.68e-05	197	220	7	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	5'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CDX2 FER1L6 CLCA1 IER3 ITM2C WNK2 ERN2	5.68e-05	197	220	7	d624f3a105b19f19a0dd253ce8de3ed13adc1f01
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	PER1 PRRC2C GNAS HELZ2 N4BP1 SIGLEC1 SRRM2	5.68e-05	197	220	7	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	PDE3A ADARB1 FN1 KIF26B EMILIN1 SETBP1 PCDH7	5.68e-05	197	220	7	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	BEST3 RHBDF1 COL20A1 TACC2 KCNK7 PCDH7 TJP3	5.68e-05	197	220	7	b8dc192fc98428bbb701cc2ea57fc8ad93397785
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A NPAS3 ADARB1 FN1 ZNF385D SETBP1 PCDH7	5.87e-05	198	220	7	d1827e3707b929e3a3562989a0c11537d344e164
ToppCell	Control-Control-Lymphocyte-T/NK-CD4+_T_activated\|Control / Disease, condition lineage and cell class	CERKL HIVEP2 MAP2 LRRN3 BCL11B HELZ2 MACF1	5.87e-05	198	220	7	ee71543559836fd59adc0da877b2ca538cba60cb
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	PER1 PRRC2C GNAS HELZ2 N4BP1 SIGLEC1 SRRM2	5.87e-05	198	220	7	44417089b62056269cac38d3134ff209c05b7007
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	BEST3 GABRQ SNAP91 ITM2C COL20A1 SDC3 PCDH7	5.87e-05	198	220	7	02d0d8a212e09c0962ab1dae6a885d26d357f66a
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PER1 PRRC2C GNAS HELZ2 N4BP1 SIGLEC1 SRRM2	5.87e-05	198	220	7	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	Sigmoid-T_cell-Tfh\|Sigmoid / Region, Cell class and subclass	EPHB6 UPB1 MAP2 C16orf46 BCL11B HELZ2 IL6R	6.05e-05	199	220	7	fa9404a021a015d1d571c324780b6eef2da47c4c
ToppCell	mild-CD4+_Tcm\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HIVEP2 MFHAS1 PTGER4 PRRC2C BCL11B MACF1 N4BP1	6.05e-05	199	220	7	06c8a0e39f7a33736548f04a5e2263334c8541cf
ToppCell	Sigmoid-(1)_T_cell-(16)_Tfh\|Sigmoid / shred on region, Cell_type, and subtype	EPHB6 UPB1 MAP2 C16orf46 BCL11B HELZ2 IL6R	6.05e-05	199	220	7	a61bf52d2d359746433623ee00337124f1f84f61
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	PDE3A ADARB1 FN1 EMILIN1 ZNF385D SETBP1 PCDH7	6.05e-05	199	220	7	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	RPAP3 GTSE1 ARX AP3B1 DCP1B RELT ARHGAP33	6.25e-05	200	220	7	691b3edf7d8449556e8bf611662eb85772959f0f
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A NPAS3 COLGALT2 ADGRA3 FN1 ZNF385D IL6R	6.25e-05	200	220	7	f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 HOOK2 WNK2 NPAS2 MUC16 TACC2 ERN2	6.25e-05	200	220	7	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PRRC2C HELZ2 ACIN1 MACF1 SIGLEC1 SRRM2 SON	6.25e-05	200	220	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	cellseq-Mesenchymal-Fibroblastic\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FN1 CD248 PI16 EMILIN1 LRRN3 HSPB6 MACF1	6.25e-05	200	220	7	8978867bf69c830b1e48cac2ad6b512dbe60f149
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A NPAS3 COLGALT2 ADGRA3 FN1 ZNF385D IL6R	6.25e-05	200	220	7	b5a54b9baf79aea01f76a161f0a39bbe87eb4945
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	RPAP3 GTSE1 ARX AP3B1 DCP1B RELT ARHGAP33	6.25e-05	200	220	7	36a110aa91a791fdf1142e7869e8aa0d342402d0
ToppCell	wk_08-11-Mesenchymal-Fibroblast\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ITM2C CNTFR FN1 CD248 EMILIN1 HSPB6 PCDH7	6.25e-05	200	220	7	482dfbbd8958b64c31568dccbffe3cc9589f876b
ToppCell	wk_08-11-Mesenchymal\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ITM2C CNTFR FN1 CD248 EMILIN1 HSPB6 PCDH7	6.25e-05	200	220	7	91416639e69621c5b36eebf061d81bccfe66f135
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	IER3 PRRC2C GNAS ITSN1 SBNO1 PCDH7	6.41e-05	138	220	6	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	LPS-antiTNF-Myeloid-Myeloid_granulocytic\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CERKL EXD1 ATXN1 MEGF9 TMEM132D ZMYM5	7.81e-05	143	220	6	4a0f26eef935fe68a1da5d319503059a8a8682dd
ToppCell	LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CERKL EXD1 ATXN1 MEGF9 TMEM132D ZMYM5	7.81e-05	143	220	6	65328a0a2f3972fac596e07933e74b2ef7cceb84
ToppCell	LPS-antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MS4A2 ITM2C PI16 ERN2 NPTXR OTOG	8.12e-05	144	220	6	013223bb2f31eb5bebdbd0908b797d28b96c6f7b
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SNAP91 MYPN BUB1 DMBT1 WNK2 HYDIN	8.43e-05	145	220	6	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	HDAC4 LRCH1 PNPLA1 MAP7D3 NBPF11 BCL11B	1.26e-04	156	220	6	fbe23876f0899853cea3c5c4f3044a9cea064d5b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 SPTBN2 FER1L6 SLC4A1 INPP5J TJP3	1.45e-04	160	220	6	174a4ab27114efcc63be36929b80680be3c35c9b
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Cyp26b1_(Deep_layer_pyramidal_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ADGRG4 ACTL7B PNPLA1 SLC4A1	1.45e-04	54	220	4	4daa84df51cc99113a9f8e86b1ae09bd76a9c991
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Cyp26b1_(Deep_layer_pyramidal_cells)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ADGRG4 ACTL7B PNPLA1 SLC4A1	1.45e-04	54	220	4	2e177a9fd0f7c033dbcfa8b41b76658d8268644c
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NR4A1 WNK2 NPAS2 MUC16 ERN2 PCDH7	1.50e-04	161	220	6	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	BAL-Mild-cDC_5\|Mild / Compartment, Disease Groups and Clusters	HDAC4 PER1 NR4A1 MAP7D3 MUC16 ARHGAP33	1.50e-04	161	220	6	7a6e8ed0b5d999efce8945d8083ab01d71be9a92
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_D2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	UPB1 OBSCN EXD3 TRMT1L LAMB2 HSPB6	1.50e-04	161	220	6	58381131e651744b5141b202f9d6063f55432db5
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A ADRB1 GNAS CD248 EMILIN1 HSPB6	1.55e-04	162	220	6	5d902bb31e691aea9749617cc88303c2448f24b8
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A ADRB1 GNAS CD248 EMILIN1 HSPB6	1.55e-04	162	220	6	c7114e24cb5525abb9780ca3d35dbcc4eabd4b64
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A ADRB1 GNAS CD248 EMILIN1 HSPB6	1.55e-04	162	220	6	f1851a173d3bcca2981d934161ec85d1cc0af5a2
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BEST3 COLGALT2 WNK2 KIF26B WDCP INPP5J	1.77e-04	166	220	6	60060b03f2abfa3cc08107ab5a9f578e60e4ae16
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BEST3 COLGALT2 WNK2 KIF26B WDCP INPP5J	1.77e-04	166	220	6	ec9161d388db5a257b8d125c14f9dd911d5d5d4a
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BEST3 COLGALT2 WNK2 KIF26B WDCP INPP5J	1.77e-04	166	220	6	4586d6725403f879fc96f67be579022587ce1906
ToppCell	facs-Marrow-B-cells-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEURL2 GATA1 MS4A2 KLF11 ZNF692 HDAC7	1.77e-04	166	220	6	13027ae342994db4540e64eb910df1f42b160931
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	SETD1B OBSCN NUMA1 VWA7 C16orf46 SON	1.77e-04	166	220	6	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	facs-Marrow-B-cells-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEURL2 GATA1 MS4A2 KLF11 ZNF692 HDAC7	1.77e-04	166	220	6	b21e45bd43f26149b9cd6e45c19241c82d54fb2f
ToppCell	Adult-Epithelial-lung_goblet_cell-D122\|Adult / Lineage, Cell type, age group and donor	PRSS22 FER1L6 WNK2 ERN2 PCDH7 TJP3	1.83e-04	167	220	6	6efbb2ef6adc8da5dd67210969f825f5cc8ed022
Drug	Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; HL60; HG-U133A	COLGALT2 SRCAP SNX19 EHD1 FN1 ITSN1 PROSER1 ERN2 N4BP1 BSCL2 CEP170B ARHGAP33	2.81e-07	194	211	12	1422_UP
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A	HIVEP2 SPTBN2 PER1 EXD3 GNAS COL7A1 POLG ERN2 SDC3 OSMR SRRM2 HCFC1	3.32e-07	197	211	12	4355_DN
Drug	Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A	TICAM1 PER1 EXD3 CLCA1 BUB1 DMBT1 MAP7D3 AP3B1 ERN2 N4BP1 ARHGAP33 TJP3	3.90e-07	200	211	12	3713_DN
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	HIVEP2 GBF1 SRCAP ATXN1 DMBT1 GTSE1 FBXO46 HDAC7 ZNF385D BAZ2A PPP6R2	2.09e-06	194	211	11	1814_DN
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A	MAGI1 HIVEP2 TICAM1 SRCAP BUB1 GNAS AP3B1 BAZ2A OSMR PCDH1 IL6R	2.20e-06	195	211	11	4345_DN
Drug	STOCK1N-35215; Up 200; 10uM; PC3; HT_HG-U133A	MAGI1 MAP2 NR4A1 SRCAP BUB1 MAP7D3 TFR2 SMO N4BP1 PCDH7 IL6R	2.31e-06	196	211	11	6380_UP
Drug	Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	GBF1 HDAC4 SBF1 EHD1 DGCR2 ITSN1 ERN2 MAPK7 PPP6R2 HCFC1 ARHGAP33	2.31e-06	196	211	11	5341_UP
Drug	Pentylenetetrazole [54-95-5]; Down 200; 29uM; PC3; HT_HG-U133A	HIVEP2 HDAC4 NACA SBF1 VPS13A GNAS DMBT1 COL7A1 CENPT ITSN1 OSMR	2.43e-06	197	211	11	2092_DN
Drug	Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; HL60; HG-U133A	TGIF2 MFHAS1 BUB1 FN1 POLG GTSE1 HDAC7 SBNO1 TRIM9 N4BP1 IL6R	2.43e-06	197	211	11	1578_UP
Drug	Benzbromarone [3562-84-3]; Down 200; 9.4uM; HL60; HT_HG-U133A	GBF1 PER1 TRIM66 EHD1 AP1G2 ITSN1 GTSE1 BAZ2A HMGXB3 SRRM2 HCFC1	2.55e-06	198	211	11	1291_DN
Drug	Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A	HIVEP2 SPTBN2 NR4A1 CLCA1 DGCR2 FN1 ERN2 CCDC88A BAZ2A INPP5J ARHGAP33	2.55e-06	198	211	11	4131_DN
Drug	aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A	SETD1B PRSS22 PER1 SRCAP ADARB1 PIK3R2 CD248 ERN2 HDAC7 N4BP1 ARHGAP33	2.68e-06	199	211	11	5201_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	CAND2 SETD1B PPRC1 NACA EXD3 CNOT3 ZNF692 BCL11B SRRM2 HCFC1	4.42e-06	170	211	10	3746_DN
Drug	Rimexolone [49697-38-3]; Up 200; 10.8uM; HL60; HT_HG-U133A	EPHB6 NPAS3 PER1 EXD3 EHD1 KIF17 CD248 HDAC7 MEGF9 SIGLEC1	1.23e-05	191	211	10	2955_UP
Drug	Mesalamine [89-57-6]; Down 200; 26.2uM; HL60; HT_HG-U133A	TICAM1 NR4A1 SBF1 ATXN1 EHD1 CENPT RHBDF1 FN1 ERN2 MEGF9	1.29e-05	192	211	10	6162_DN
Drug	Zidovudine, AZT [30516-87-1]; Down 200; 15uM; PC3; HT_HG-U133A	SBF1 PIK3R2 COL7A1 FSD1 ERN2 NPTXR HSPB6 MAPK7 PPP6R2 TJP3	1.35e-05	193	211	10	6733_DN
Drug	Sulfaquinoxaline sodium salt [967-80-6]; Down 200; 12.4uM; MCF7; HT_HG-U133A	HIVEP2 PER1 NR4A1 SRCAP ADARB1 VPS13A CNOT3 FN1 HSPB6 PCDH1	1.41e-05	194	211	10	6090_DN
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	PPRC1 TICAM1 ATXN1 CENPT FSD1 ERN2 TRIM9 SETBP1 N4BP1 HCFC1	1.41e-05	194	211	10	1226_DN
Drug	Sulfamerazine [127-79-7]; Down 200; 15.2uM; PC3; HT_HG-U133A	SPTBN2 CLCA1 ATXN1 MCM3AP BUB1 DGCR2 ERN2 TRIM9 N4BP1 PCDH1	1.48e-05	195	211	10	3718_DN
Drug	Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A	SRCAP CLCA1 EHD1 PRR36 ERN2 ZNF385D TRIM9 N4BP1 PCDH7 HCFC1	1.54e-05	196	211	10	2086_UP
Drug	GSK-3beta Inhibitor VIII; Up 200; 10uM; MCF7; HT_HG-U133A	HIVEP2 POGZ SRCAP EHD1 VPS13A AP1G2 DGCR2 N4BP1 IL6R ZMYM5	1.54e-05	196	211	10	7092_UP
Drug	Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A	TICAM1 SPTBN2 SRCAP LRCH1 SBF1 ITM2C COL7A1 SDC3 N4BP1 OSMR	1.54e-05	196	211	10	3878_DN
Drug	Hesperidin [520-26-3]; Down 200; 6.6uM; MCF7; HT_HG-U133A	HIVEP2 TICAM1 NR4A1 TOX4 SBF1 AP3B1 MEGF9 SDC3 SRRM2 ZMYM5	1.54e-05	196	211	10	2648_DN
Drug	Hesperetin [520-33-2]; Up 200; 13.2uM; HL60; HG-U133A	EPHB6 CAND2 NR4A1 AP1G2 ITSN1 SLC4A1 MACF1 SMO N4BP1 BSCL2	1.54e-05	196	211	10	2031_UP
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A	CAND2 MAP2 COLGALT2 SRCAP DGCR2 NUMA1 ZNF385D BCL11B BAZ2A ARHGAP33	1.61e-05	197	211	10	3801_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	MAP2 SPTBN2 NR4A1 SRCAP ADARB1 VPS13A PRR36 ERN2 INPP5J ARHGAP33	1.61e-05	197	211	10	3886_DN
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A	SETD1B PRSS22 PIK3R2 BUB1 ERN2 BAZ2A HMGXB3 PPP6R2 HCFC1 TJP3	1.61e-05	197	211	10	6941_DN
Drug	Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; HL60; HG-U133A	TGIF2 CLCA1 EHD1 HOOK2 DGCR2 POLG ITSN1 ERN2 HSPB6 SIGLEC1	1.61e-05	197	211	10	1776_UP
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A	MAP2 SPTBN2 PER1 EXD3 BUB1 ITM2C DGCR2 PRR36 ERN2 NPTXR	1.69e-05	198	211	10	3883_DN
Drug	Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A	GBF1 EXD3 SBF1 COL7A1 PRR36 FBXO46 WDCP SDC3 PCDH7 ARHGAP33	1.69e-05	198	211	10	4791_DN
Drug	Caffeic acid [3331-39-5]; Up 200; 22.2uM; MCF7; HT_HG-U133A	PRSS22 SRCAP MCM3AP ERN2 BAZ2A N4BP1 PPP6R2 HCFC1 INPP5J ZMYM5	1.69e-05	198	211	10	5352_UP
Drug	Benzonatate [104-31-4]; Up 200; 6.6uM; PC3; HT_HG-U133A	MFHAS1 SRCAP ADARB1 EXD3 DMBT1 NPAS2 FN1 ERN2 PCDH7 HCFC1	1.76e-05	199	211	10	6334_UP
Drug	Perhexiline maleate [6724-53-4]; Up 200; 10.2uM; PC3; HT_HG-U133A	MKRN3 UPB1 MAP2 PER1 NR4A1 DGCR2 EMILIN1 TFR2 HSPB6 MUC7	1.76e-05	199	211	10	5081_UP
Drug	Glipizide [29094-61-9]; Up 200; 9uM; HL60; HG-U133A	SNX19 CLCA1 TAF6 DGCR2 CENPT ITSN1 GTSE1 N4BP1 BSCL2 PPP6R2	1.84e-05	200	211	10	2008_UP
Drug	PHA-00745360 [351320-33-7]; Down 200; 10uM; MCF7; HT_HG-U133A	MAP2 SRCAP TRIM66 EXD3 SBF1 EHD1 BUB1 ITM2C COL7A1 NUMA1	1.84e-05	200	211	10	3907_DN
Drug	Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; PC3; HT_HG-U133A	SRCAP EXD3 CLCA1 SBF1 SLC4A1 MEGF9 NPTXR HSPB6 PCDH7 INPP5J	1.84e-05	200	211	10	6333_UP
Drug	Pralidoxime chloride [51-15-0]; Up 200; 23.2uM; PC3; HT_HG-U133A	PER1 LRCH1 ATXN1 VPS13A CNTFR NPAS2 COL7A1 POLG HDAC7 HCFC1	1.84e-05	200	211	10	6283_UP
Drug	SAHA; Down 200; 10uM; PC3; HT_HG-U133A	HIVEP2 CAND2 PPRC1 CNOT3 ZNF692 BCL11B SRRM2 HCFC1 IL6R	4.43e-05	178	211	9	4444_DN
Drug	DBTC	NR4A1 SNAP91 NUMA1 ACIN1 YY1AP1 MUC7	5.99e-05	73	211	6	CID000101938
Drug	APTS	EPO PPRC1 MS4A2 LAMB2	6.59e-05	24	211	4	CID004346575
Drug	Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A	TGIF2 CAND2 PI4KA AP1G2 GNAS NPAS2 DGCR2 TACC2 TRIM9	7.35e-05	190	211	9	7145_DN
Drug	Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A	TGIF2 PRRC2C BUB1 GNL2 CENPT ITSN1 GTSE1 WDCP PPP6R2	7.96e-05	192	211	9	7176_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	TICAM1 SRCAP EXD3 PIK3R2 EHD1 ERN2 MAPK7 PPP6R2 IL6R	8.28e-05	193	211	9	5239_DN
Drug	Benzocaine [94-09-7]; Up 200; 24.2uM; PC3; HT_HG-U133A	EPO GABRQ ADRB1 CNOT3 HDAC7 EMILIN1 ZNF385D MEGF9 TJP3	8.62e-05	194	211	9	4224_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	PER1 NR4A1 SRCAP EXD3 EHD1 AP1G2 KIF17 NUMA1 PPP6R2	8.62e-05	194	211	9	6171_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	SRCAP EXD3 SBF1 COL7A1 PRR36 ITSN1 GTSE1 ERN2 PCDH7	8.62e-05	194	211	9	3828_DN
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A	ADARB1 TRIM66 ITM2C DMBT1 CNOT3 BAZ2A SDC3 HCFC1 ARHGAP33	8.96e-05	195	211	9	5240_UP
Drug	Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	CAND2 ADARB1 MCM3AP EHD1 DMBT1 FN1 PRR36 LRRN3 SDC3	8.96e-05	195	211	9	6039_UP
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; PC3; HT_HG-U133A	GBF1 SRCAP TRIM66 BUB1 CENPT HDAC7 ZNF385D SDC3 TJP3	8.96e-05	195	211	9	1823_DN
Drug	(R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; PC3; HT_HG-U133A	POGZ ATXN1 DGCR2 ERN2 TRIM9 SDC3 MAPK7 PPP6R2 IL6R	8.96e-05	195	211	9	5814_DN
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	UPB1 TICAM1 SRCAP DGCR2 RHBDF1 NUMA1 TFR2 N4BP1 ARHGAP33	8.96e-05	195	211	9	6163_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	SRCAP EXD3 EHD1 FN1 FSD1 ERN2 MAPK7 SRRM2 IL6R	8.96e-05	195	211	9	5241_DN
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; PC3; HT_HG-U133A	SPTBN2 PRSS22 PER1 NR4A1 MCM3AP MAP7D3 HDAC7 N4BP1 HCFC1	9.32e-05	196	211	9	3790_DN
Drug	Flurandrenolide [1524-88-5]; Up 200; 9.2uM; PC3; HT_HG-U133A	CAND2 PER1 DMBT1 DGCR2 HSPB6 MAPK7 HCFC1 IL6R INPP5J	9.32e-05	196	211	9	7378_UP
Drug	Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A	GBF1 SPTBN2 SBF1 CNOT3 DGCR2 NPTXR MAPK7 PPP6R2 TJP3	9.32e-05	196	211	9	5079_DN
Drug	Retinoic acid [302-79-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	TRIM66 ATXN1 PIK3R2 COL7A1 NUMA1 MEGF9 BAZ2A SETBP1 SDC3	9.32e-05	196	211	9	5767_DN
Drug	Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A	MAP2 COLGALT2 NR4A1 EXD3 CLCA1 AP1G2 COL7A1 SMO N4BP1	9.69e-05	197	211	9	3728_DN
Drug	Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A	HDAC4 MEX3C SBF1 COL7A1 ERN2 SDC3 PPP6R2 IL6R ZMYM5	9.69e-05	197	211	9	4787_DN
Drug	Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; PC3; HT_HG-U133A	NR4A1 ADARB1 FN1 NUMA1 EMILIN1 LRRN3 SMO MAPK7 IL6R	9.69e-05	197	211	9	5060_UP
Drug	Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A	COLGALT2 NR4A1 GNAS COL7A1 HDAC7 TFR2 CCDC88A SETBP1 SIGLEC1	9.69e-05	197	211	9	3926_UP
Drug	MK-886; Down 200; 1uM; MCF7; HG-U133A	HIVEP2 MAP2 NR4A1 SBF1 DGCR2 ITSN1 ERN2 BCL11B N4BP1	9.69e-05	197	211	9	601_DN
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	PER1 BUB1 NPAS2 DGCR2 AP3B1 CCDC88A PCDH1 PCDH7 HCFC1	9.69e-05	197	211	9	3748_DN
Drug	N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA	MAGI1 HIVEP2 PER1 PIK3R2 NUMA1 HMGXB3 N4BP1 PPP6R2 INPP5J	9.69e-05	197	211	9	959_UP
Drug	Amoxicillin [26787-78-0]; Up 200; 11uM; MCF7; HT_HG-U133A	PER1 CLCA1 ITM2C DGCR2 CENPT KIF26B NUMA1 TFR2 MAPK7	9.69e-05	197	211	9	2620_UP
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A	MFHAS1 SRCAP SBF1 CNOT3 DGCR2 FN1 BAZ2A MAPK7 ZMYM5	9.69e-05	197	211	9	5746_DN
Drug	Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	DGCR2 ITSN1 NUMA1 PROSER1 BAZ2A SRRM2 PPP6R2 IL6R ARHGAP33	9.69e-05	197	211	9	3247_UP
Drug	Aconitine [302-27-2]; Up 200; 6.2uM; MCF7; HT_HG-U133A	GNAS CNOT3 FN1 PRR36 NUMA1 TFR2 LRRN3 MAPK7 TJP3	9.69e-05	197	211	9	6797_UP
Drug	Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A	NR4A1 CD248 PRR36 BAZ2A SDC3 SRRM2 HCFC1 INPP5J ARHGAP33	9.69e-05	197	211	9	2766_UP
Drug	Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; PC3; HT_HG-U133A	HGFAC SP2 MAP2 ADRB1 CNTFR KIF26B BAZ2A NPTXR N4BP1	1.01e-04	198	211	9	4230_UP
Drug	Evoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A	EXD3 SBF1 CNTFR ERN2 FBXO46 ZNF385D ACIN1 SRRM2 PPP6R2	1.01e-04	198	211	9	3681_DN
Drug	Articaine hydrochloride [23964-57-0]; Down 200; 12.4uM; PC3; HT_HG-U133A	TGIF2 COLGALT2 TRIM66 VPS13A POLG AP3B1 ERN2 MEGF9 N4BP1	1.01e-04	198	211	9	7272_DN
Drug	Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A	TGIF2 TICAM1 SBF1 DGCR2 FN1 ERN2 SDC3 PPP6R2 ZMYM5	1.01e-04	198	211	9	6790_DN
Drug	Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A	HDAC4 PER1 SRCAP LRCH1 SBF1 VPS13A DGCR2 N4BP1 ZMYM5	1.01e-04	198	211	9	5334_UP
Drug	CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A	MFHAS1 PER1 POGZ SRCAP ADARB1 EXD3 AP1G2 N4BP1 TJP3	1.01e-04	198	211	9	7549_UP
Drug	ST021200; Down 200; 10uM; MCF7; HT_HG-U133A	HDAC4 TICAM1 ADARB1 EXD3 VPS13A COL7A1 ERN2 MEGF9 MAPK7	1.01e-04	198	211	9	7488_DN
Drug	Urosiol [128-13-2]; Down 200; 10.2uM; PC3; HT_HG-U133A	TICAM1 POLG AP3B1 ERN2 FBXO46 OSMR SRRM2 PPP6R2 HCFC1	1.01e-04	198	211	9	7243_DN
Drug	vinblastine sulfate; Down 200; 0.1uM; PC3; HT_HG-U133A	HIVEP2 NACA POGZ SBF1 VPS13A NPAS2 ITSN1 ERN2 SDC3	1.01e-04	198	211	9	7556_DN
Drug	Gemfibrozil [25812-30-0]; Up 200; 16uM; HL60; HG-U133A	NACA NR4A1 EHD1 MEGF9 SBNO1 TRIM9 N4BP1 SIGLEC1 PCDH7	1.01e-04	198	211	9	1430_UP
Drug	Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; PC3; HT_HG-U133A	TGIF2 MFHAS1 SPTBN2 NR4A1 CNOT3 COL7A1 BAZ2A N4BP1 OSMR	1.05e-04	199	211	9	4668_DN
Drug	Acetazolamide [59-66-5]; Down 200; 18uM; PC3; HT_HG-U133A	HIVEP2 GBF1 GPATCH8 SRCAP POLG HDAC7 BAZ2A SRRM2 PPP6R2	1.05e-04	199	211	9	1808_DN
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; PC3; HT_HG-U133A	TICAM1 PER1 AP1G2 DGCR2 KLF11 AP3B1 ERN2 WDCP MAPK7	1.05e-04	199	211	9	5824_DN
Drug	Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; PC3; HT_HG-U133A	MFHAS1 NPAS2 COL7A1 NUMA1 HDAC7 SETBP1 SDC3 MAPK7 PPP6R2	1.05e-04	199	211	9	5753_DN
Drug	Ketoconazole [65277-42-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A	EPHB6 NR4A1 CLCA1 EHD1 DGCR2 HDAC7 PCDH1 IL6R INPP5J	1.05e-04	199	211	9	2640_UP
Drug	Eburnamonine (-) [4880-88-0]; Up 200; 13.6uM; MCF7; HT_HG-U133A	HDAC4 SRCAP TRIM66 MCM3AP DGCR2 FN1 BAZ2A IL6R TJP3	1.05e-04	199	211	9	6802_UP
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	SBF1 MCM3AP EHD1 CENPT FN1 NPTXR SRRM2 PPP6R2 HCFC1	1.05e-04	199	211	9	7439_UP
Drug	Ribavirin [36791-04-5]; Down 200; 16.4uM; PC3; HT_HG-U133A	SETD1B HDAC4 COLGALT2 SRCAP TRIM66 CNOT3 NPAS2 CENPT POLG	1.05e-04	199	211	9	7316_DN
Drug	exemestane; Up 200; 0.01uM; MCF7; HG-U133A	SETD1B SRCAP CLCA1 CNTFR MAP7D3 NUMA1 ERN2 BAZ2A SON	1.05e-04	199	211	9	165_UP
Drug	Clebopride maleate [84370-95-6]; Up 200; 8.2uM; MCF7; HT_HG-U133A	TICAM1 SRCAP ITM2C DGCR2 ERN2 HDAC7 BAZ2A SDC3 HCFC1	1.05e-04	199	211	9	5412_UP
Drug	Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; HL60; HG-U133A	EHD1 SBNO1 BAZ2A WDCP ACIN1 MACF1 N4BP1 HCFC1 CEP170B	1.05e-04	199	211	9	2046_DN
Drug	Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; PC3; HT_HG-U133A	SPTBN2 COLGALT2 NR4A1 SRCAP PRR36 ERN2 BCL11B N4BP1 OSMR	1.05e-04	199	211	9	3696_DN
Drug	Ioxaglic acid [59017-64-0]; Up 200; 3.2uM; MCF7; HT_HG-U133A	SYNPO2L NR4A1 ADARB1 EHD1 DMBT1 HDAC7 TFR2 MAPK7 PCDH1	1.09e-04	200	211	9	3528_UP
Drug	colchicine; Up 200; 0.1uM; MCF7; HG-U133A	GPATCH8 SNX19 PIK3C2A EHD1 CNTFR MAP7D3 POLG BAZ2A SMO	1.09e-04	200	211	9	644_UP
Drug	Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A	PRSS22 PER1 SRCAP LRCH1 ERN2 NPTXR SDC3 HMGXB3 ZMYM5	1.09e-04	200	211	9	7336_DN
Drug	Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	TICAM1 SBF1 DGCR2 COL7A1 ERN2 MEGF9 PCDH7 HCFC1 ZMYM5	1.09e-04	200	211	9	4818_DN
Drug	indomethacin, USP; Up 200; 100uM; MCF7; HG-U133A	GPATCH8 EHD1 CNTFR DGCR2 POLG FSD1 ERN2 BAZ2A SON	1.09e-04	200	211	9	453_UP
Drug	Oxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; PC3; HT_HG-U133A	MFHAS1 PIK3R2 COL7A1 FN1 MEGF9 OSMR PCDH1 ZMYM5 TJP3	1.09e-04	200	211	9	5772_DN
Drug	nicarbazin	SALL3 TMEM132D ACIN1	1.23e-04	11	211	3	CID000009507
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	SETD1B NPAS2 KLF11 ZNF692 BCL11B SRRM2 HCFC1 IL6R	1.45e-04	163	211	8	7285_DN
Drug	LOPAC	ADRB1 PI4KA FN1 ACIN1	1.63e-04	30	211	4	CID000062696
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	HIVEP2 SETD1B CNOT3 NPAS2 ZNF692 HDAC7 SRRM2 HCFC1	2.27e-04	174	211	8	7105_DN
Disease	Colorectal Carcinoma	MKRN3 EPHB6 SALL3 MAP2 SPTBN2 OBSCN PER1 MCM3AP BUB1 VPS13A NPAP1 GNAS COL7A1 FN1 CD248 ZNF385D BCL11B SETBP1 ACIN1	4.87e-07	702	204	19	C0009402
Disease	platelet component distribution width	HIVEP2 ZFPM1 LRCH1 JMY EXD3 TOX4 ADRB1 PRRC2C HOOK2 GNAS NPAS2 VWA7 HDAC7 BAZ2A MACF1 EIF2AK4 SIGLEC1	2.20e-05	755	204	17	EFO_0007984
Disease	calcium measurement	HGFAC PDE3A HDAC4 WDR81 ZFPM1 ADRB1 GNAS DMBT1 KLF11 NUMA1 SLC4A1 BCL11B MACF1 EIF2AK4 ZMYM5	3.48e-05	628	204	15	EFO_0004838
Disease	Gastrointestinal defect and immunodeficiency syndrome	PI4KA TTC7A	4.76e-05	2	204	2	cv:C5234880
Disease	interleukin-6 receptor subunit alpha measurement	TDRD10 IL6R	4.76e-05	2	204	2	EFO_0801731
Disease	Paroxysmal atrial fibrillation	CAND2 NACA SYNPO2L BEST3 MEX3C ATXN1 MYPN	1.11e-04	156	204	7	C0235480
Disease	familial atrial fibrillation	CAND2 NACA SYNPO2L BEST3 MEX3C ATXN1 MYPN	1.11e-04	156	204	7	C3468561
Disease	Persistent atrial fibrillation	CAND2 NACA SYNPO2L BEST3 MEX3C ATXN1 MYPN	1.11e-04	156	204	7	C2585653
Disease	brain connectivity measurement	MAGI1 MAP2 MFHAS1 LRCH1 WNK2 TANGO6 KIF26B GTSE1 BCL11B PCDH7 SH3RF3	1.17e-04	400	204	11	EFO_0005210
Disease	brain measurement, neuroimaging measurement	MAGI1 MAP2 GPATCH8 MBD6 LRCH1 WNK2 TANGO6 KIF26B RFX4 BCL11B SBNO1 MACF1 SH3RF3	1.29e-04	550	204	13	EFO_0004346, EFO_0004464
Disease	Atrial Fibrillation	CAND2 NACA SYNPO2L BEST3 MEX3C ATXN1 MYPN	1.30e-04	160	204	7	C0004238
Disease	Brachydactyly	HDAC4 GNAS	2.83e-04	4	204	2	C0221357
Disease	aortic aneurysm (is_marker_for)	HDAC4 PTGER4	2.83e-04	4	204	2	DOID:3627 (is_marker_for)
Disease	interleukin-6 receptor measurement	TDRD10 IL6R	4.69e-04	5	204	2	EFO_0004814
Disease	aspartate aminotransferase measurement	MAGI1 HGFAC PDE3A MFHAS1 OBSCN ADRB1 ATXN1 MYPN WNK2 CNTFR NPAS2 KCNK7 BAZ2A TMEM132D HMGXB3 TJP3	5.86e-04	904	204	16	EFO_0004736
Disease	West Syndrome	UPB1 AIMP2 ARX	5.92e-04	24	204	3	C0037769
Disease	renal overload-type gout	SPATA31C1 SPATA31C2	7.01e-04	6	204	2	EFO_0021525
Disease	mean platelet volume	EPO HIVEP2 SETD1B CDK12 NACA SRCAP LRCH1 ZDHHC1 TOX4 PI4KA GNAS NUMA1 VWA7 HDAC7 BAZ2A SETBP1 IL6R	7.74e-04	1020	204	17	EFO_0004584
Disease	Precocious Puberty	MKRN3 GNAS	9.76e-04	7	204	2	C0034013
Disease	Glycosuria	CERKL N4BP1	9.76e-04	7	204	2	HP_0003076
Disease	Cryptogenic sexual precocity	MKRN3 GNAS	9.76e-04	7	204	2	C0271527
Disease	Central Precocious Puberty	MKRN3 GNAS	9.76e-04	7	204	2	C0342543
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	HGFAC PDE3A MFHAS1 ADRB1 SEC16A HELZ2 MACF1	1.01e-03	225	204	7	EFO_0008317, EFO_0020947
Disease	amyotrophic lateral sclerosis (is_marker_for)	EPO HDAC4 ADARB1	1.04e-03	29	204	3	DOID:332 (is_marker_for)
Disease	Mood Disorders	HDAC4 MAP2 ADRB1 VPS13A POLG BSCL2	1.15e-03	168	204	6	C0525045
Disease	Intellectual Disability	HIVEP2 HDAC4 POGZ GNAS TAF6 MAP7D3 BCL11B SETBP1 ACIN1 MACF1	1.17e-03	447	204	10	C3714756
Disease	eosinophil cationic protein measurement	SPATA31C1 SPATA31C2	1.30e-03	8	204	2	EFO_0010913
Disease	Testotoxicosis	MKRN3 GNAS	1.30e-03	8	204	2	C1504412
Disease	Congenital Hydrocephalus	WDR81 HYDIN	1.30e-03	8	204	2	C0020256
Disease	non-high density lipoprotein cholesterol measurement	EPO HGFAC WDR81 ZFPM1 ADRB1 ITM2C FN1 HEATR5A PHC1 SBNO1 PPP6R2 MUC7 HYDIN	1.47e-03	713	204	13	EFO_0005689
Disease	renovascular hypertension (implicated_via_orthology)	ADRB1 FN1	1.66e-03	9	204	2	DOID:1591 (implicated_via_orthology)
Disease	longitudinal alcohol consumption measurement	SPATA31C1 SPATA31C2	1.66e-03	9	204	2	EFO_0007645
Disease	pulse pressure measurement	EPO HGFAC PDE3A MFHAS1 SYNPO2L POGZ GPATCH8 SRCAP LRCH1 SNX19 TRIM66 PIK3C2A ATXN1 MYPN NPAS2 FN1 HEATR5A EIF2AK4 HCFC1 HYDIN	1.66e-03	1392	204	20	EFO_0005763
Disease	cortical thickness	MAGI1 EXD1 SPTBN2 MBD6 LRCH1 SNAP91 PI4KA WNK2 TACC2 RFX4 BCL11B CCDC88A MEGF9 MACF1 OSMR PCDH7 SH3RF3	1.97e-03	1113	204	17	EFO_0004840
Disease	PRADER-WILLI SYNDROME	MKRN3 NPAP1	2.06e-03	10	204	2	176270
Disease	Prader-Willi syndrome	MKRN3 NPAP1	2.06e-03	10	204	2	cv:C0032897
Disease	PR interval	MAGI1 PDE3A SYNPO2L OBSCN ZFPM1 LRCH1 ADRB1 LAMB2 RFX4 MACF1	2.47e-03	495	204	10	EFO_0004462
Disease	cortical surface area measurement	MAGI1 PDE3A MAP2 MFHAS1 NPAS3 MBD6 LRCH1 PRRC2C HOOK2 WNK2 TANGO6 KIF26B RFX4 BCL11B CCDC88A MDC1 MACF1 PCDH7 SH3RF3	2.61e-03	1345	204	19	EFO_0010736
Disease	comparative body size at age 10, self-reported	MAGI1 HDAC4 MFHAS1 NPAS3 ZDHHC1 GNAS NPBWR1 AP3B1 PCDH7	2.73e-03	420	204	9	EFO_0009819
Disease	reticulocyte measurement	PER1 ZFPM1 LRCH1 ADRB1 ATXN1 VPS13A HOOK2 AIMP2 SLC4A1 TFR2 BCL11B MEGF9 SETBP1 EIF2AK4 SIGLEC1 OSMR	2.80e-03	1053	204	16	EFO_0010700
Disease	Royer Syndrome	MKRN3 NPAP1	3.00e-03	12	204	2	C0265222
Disease	Cooley's anemia	EPO TFR2	3.00e-03	12	204	2	C0002875
Disease	Thalassemia Intermedia	EPO TFR2	3.00e-03	12	204	2	C0271979
Disease	airway wall thickness measurement	ZNF385D BCL11B	3.00e-03	12	204	2	EFO_0006898
Disease	Thalassemia Minor	EPO TFR2	3.00e-03	12	204	2	C0085578
Disease	beta Thalassemia	EPO TFR2	3.00e-03	12	204	2	C0005283
Disease	neuroimaging measurement	MAGI1 MAP2 MBD6 LRCH1 SNAP91 PRRC2C WNK2 KIF26B TACC2 KCNK7 BCL11B CCDC88A SBNO1 MACF1 PCDH7 SH3RF3	3.24e-03	1069	204	16	EFO_0004346
Disease	retinal vasculature measurement	PDE3A MAP2 LRCH1 MYPN LRIT2 NPBWR1 FBXO46 TMEM132D ACIN1 OSMR	3.36e-03	517	204	10	EFO_0010554
Disease	hepatocyte growth factor measurement	HGFAC ATXN1 TMEM132D	3.50e-03	44	204	3	EFO_0006903
Disease	Anemia, Hemolytic, Acquired	EPO SLC4A1	3.53e-03	13	204	2	C0002879
Disease	Anemia, Hemolytic	EPO SLC4A1	3.53e-03	13	204	2	C0002878
Disease	Anemia, Microangiopathic	EPO SLC4A1	3.53e-03	13	204	2	C0002889
Disease	interleukin 6 receptor subunit alpha measurement	TDRD10 IL6R	3.53e-03	13	204	2	EFO_0008187
Disease	egg allergy measurement, parental genotype effect measurement	SPATA31C1 SPATA31C2	3.53e-03	13	204	2	EFO_0005939, EFO_0007018
Disease	Microangiopathic hemolytic anemia	EPO SLC4A1	3.53e-03	13	204	2	C0221021
Disease	iron deficiency anemia (biomarker_via_orthology)	FN1 SLC4A1	3.53e-03	13	204	2	DOID:11758 (biomarker_via_orthology)
Disease	Prader-Willi Syndrome	MKRN3 NPAP1	3.53e-03	13	204	2	C0032897
Disease	heart rate variability measurement, response to antipsychotic drug	COLGALT2 SAP130 OSMR	3.97e-03	46	204	3	EFO_0008003, GO_0097332
Disease	pneumonia	EXD3 HELZ2 IL6R	4.22e-03	47	204	3	EFO_0003106
Disease	mean corpuscular hemoglobin concentration	SETD1B CDK12 ZFPM1 DMXL1 ATXN1 VPS13A SEC16A ITM2C HOOK2 ITSN1 HDAC7 SLC4A1 TFR2 MACF1 EIF2AK4 IL6R	4.45e-03	1105	204	16	EFO_0004528
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	HGFAC PDE3A MFHAS1 SEC16A HELZ2 MACF1	4.59e-03	222	204	6	EFO_0008317, EFO_0020943
Disease	myelodysplastic syndrome (implicated_via_orthology)	GATA1 POLG	4.71e-03	15	204	2	DOID:0050908 (implicated_via_orthology)
Disease	infant head circumference	ADRB1 SBNO1	4.71e-03	15	204	2	EFO_0004577
Disease	Hemoglobin F Disease	EPO TFR2	4.71e-03	15	204	2	C0019025
Disease	Parkinson's disease (implicated_via_orthology)	PPRC1 INSRR NR4A1 VPS13A NPBWR1	4.80e-03	157	204	5	DOID:14330 (implicated_via_orthology)
Disease	Adenoid Cystic Carcinoma	MAGI1 INSRR SRCAP SON	5.19e-03	100	204	4	C0010606
Disease	amygdala volume change measurement	SPATA31C1 SPATA31C2	5.35e-03	16	204	2	EFO_0021490
Disease	Idiopathic pulmonary arterial hypertension	HDAC4 EIF2AK4	5.35e-03	16	204	2	C3203102
Disease	Familial primary pulmonary hypertension	HDAC4 EIF2AK4	6.04e-03	17	204	2	C0340543

Protein segments in the cluster

Peptide	Gene	Start	Entry
AELPPSSEVLASVFP	PI16	361	Q6UXB8
TQVPALFSAALVPPV	LINC00311	31	Q8N616
PAATLFQTSALPPAL	ZNF385D	361	Q9H6B1
PAVLIQLSPPNTDAD	ACIN1	446	Q9UKV3
PEVLITAAEAPVPTS	BEST3	501	Q8N1M1
AATAARLLVPASPPA	ADRB1	26	P08588
LALPQEPSSVPAFEV	MS4A2	11	Q01362
PSPFTPVSALLLAEI	ALDH9A1	181	P49189
DTRLLANTSPPPSVL	CIBAR2	231	Q6ZTR7
RSVPEPLSPVSSLQA	CDX2	276	Q99626
EAPSAPVILPSAEQT	CDK12	1181	Q9NYV4
AVLVSDPPLSPSSNR	ACTL7B	146	Q9Y614
AALVSPATSQSIAPP	BUB1	371	O43683
VEAAAPPPILSSSVE	EIF2AK4	696	Q9P2K8
LPPTDAPSEQALLSL	SLC4A1	321	P02730
PVLISTAAPVDSVFP	ADGRG4	471	Q8IZF6
PASSAVLPAVSLEVP	BAZ2A	471	Q9UIF9
SSLELAQVLPPDTLP	ADGRA3	66	Q8IWK6
IVEASIQLPPSLFSP	ADGRA3	606	Q8IWK6
PPQAPDALVLRTQAT	CD248	566	Q9HCU0
ISVPAATQPAALPTL	CD248	606	Q9HCU0
AAPVPTEPQASQLLD	AP1G2	611	O75843
PPVDLFATASAAVPV	SNAP91	326	O60641
QLIPPTANPVTSAVA	ATXN1	146	P54253
VVQSVASPAAAPPTL	ATXN1	556	P54253
VAAQSPPSPASAEAL	CEP170B	1541	Q9Y4F5
ASINPATDIPLLPSI	DMXL1	361	Q9Y485
LDDFNPVSTPVALPT	AP3B1	821	O00203
LEDIPQALVATSPPS	CNOT3	231	O75175
SPSPAAQISLLTDPE	C16orf46	281	Q6P387
VSLRLALPPPTENSS	OSMR	951	Q99650
APAEVISSQATPPLL	RFWD3	56	Q6PCD5
EIILTEAAAPTPSPV	RFX4	496	Q33E94
PSLAPPAVTSVVEQL	GOLGA6A	286	Q9NYA3
LPEDSPPQTVVALFT	PCDHB1	356	Q9Y5F3
PPDASPANLLTSLVR	NR4A1	356	P22736
EASTPALPRSATLPQ	NPAS2	436	Q99743
DLPVSILASPTTEQP	HCFC1	976	P51610
VPAPPQIATSTSLLA	MAPK7	651	Q13164
PTNISPSELDALTPL	MUC16	10641	Q8WXI7
LPLPEAAPTQAQADL	PCDHB13	671	Q9Y5F0
PLSAPPTLIALNSAL	MBD6	666	Q96DN6
AAASPVASLLEPTAP	FOXB2	401	Q5VYV0
EPLVAPQLLPSSSLE	GNL2	466	Q13823
PQLLPSSSLEVVPEA	GNL2	471	Q13823
IAPAVPSIPAETSLA	HDAC4	316	P56524
RAPSVALPVAQVPTD	HSPB6	56	O14558
VLSIQAAPASAQAPP	HSPB6	141	O14558
APTPVSAVLEPFNLT	IER3	121	P46695
PETVVPTAPELQASA	MDC1	1486	Q14676
SLTAIPEPASPQLLE	MDC1	1766	Q14676
NLPAAETPSIPEALQ	MAGEB18	51	Q96M61
TALPPVNSSIIAAPI	MAGI1	266	Q96QZ7
LALSDAEQPPPATEL	JMY	206	Q8N9B5
DALESPASPQLVLPA	MFHAS1	46	Q9Y4C4
PAQALHAPDSLSIPS	LRIT2	346	A6NDA9
FLPVPSAPVIDLAES	FSD1	161	Q9BTV5
VSSLPITPAQAPLAS	GABRQ	396	Q9UN88
PSLDPTSTPVDNLAA	HOOK2	436	Q96ED9
LLQLLPPDSPTSAVD	ERN2	691	Q76MJ5
APVSEVSITQFLPLP	KIF26B	1246	Q2KJY2
ASPAPEAPATSLLND	EXD1	51	Q8NHP7
PSVAPSLFQLSVQPE	MCM3AP	1051	O60318
QDELALSTLPPAAPA	KCNK7	286	Q9Y2U2
STAILNAARIPVPPA	PRSS22	26	Q9GZN4
LPISVDSPPAAADSN	CCDC88A	1831	Q3V6T2
PLPDVLNATEPLSTA	HMGXB3	666	Q12766
SLAPLESQPITFTPE	GPATCH8	1301	Q9UKJ3
PSPAPSLDTDIQELS	PER1	476	O15534
SAPVQAPLALVPEEA	PER1	601	O15534
ATEVPASQPAPLLSA	FBXO46	61	Q6PJ61
VLPVTPILSPSFSAQ	PIK3C2A	116	O00443
PNFASPVITLAIPEN	PCDH1	166	Q08174
PTFPSPVLTLTVEEN	PCDH7	141	O60245
LITDLLADPSLPPNV	PDE3A	356	Q14432
SLSPDRLNSPVTIPA	PTGER4	11	P35408
ASSPRQAEPSPALTL	ZFPM1	126	Q8IX07
TSQLSPADLIPLEVP	POLG	236	P54098
QTLAPVPAALTPASE	PHRF1	1516	Q9P1Y6
VPAALTPASEPASQA	PHRF1	1521	Q9P1Y6
STIINLLDPPPEVSA	PI4KA	866	P42356
SSLSAFPAQPPVEEL	PNPLA1	441	Q8N8W4
LAAAVSNPEEPTSPA	MACF1	1231	O94854
VLTPEELSSPAASVP	MACF1	1261	O94854
TPEEPASPAAAVSNL	MACF1	1276	O94854
SEPQPFVPALSVATL	LRCH1	6	Q9Y2L9
LAATSPAQSPETTPL	MEGF9	91	Q9H1U4
VLAATLAQAPAPDVP	LAMB2	26	P55268
LFSDTVLPLAPSQPL	TEPSIN	131	Q96N21
PAQAASPFIPLDELS	PABIR1	271	Q96E09
LSLSASPVPASLAQP	ADARB1	206	P78563
PSLAPPAVTSVVEQL	GOLGA6B	286	A6NDN3
EPNATATPAIPTILV	HGFAC	46	Q04756
ALDATQVPSPLPLAQ	MED26	306	O95402
ASLAPVPEFSLPDLV	NEURL2	91	Q9BR09
LPARVNLSAAPAPVS	NPTXR	211	O95502
LAAEQLTAPPSASPT	GTSE1	386	Q9NYZ3
LEPLAVTPDAASQPL	GTSE1	631	Q9NYZ3
VTPDAASQPLIDLPL	GTSE1	636	Q9NYZ3
LSDLSEPVNVSFPVP	HIDE1	101	A8MVS5
PAPASATEILLTPAR	ITM2C	26	Q9NQX7
LPAQLLEVLSTPTPF	SBF1	271	O95248
TPLTLPVQSPLATAA	PROSER1	551	Q86XN7
PVSAAPFPLNLSTAV	PROSER1	756	Q86XN7
VALSPASVDEAPQPS	OBSCN	4711	Q5VST9
SFLLALPAPLVTPEA	PIK3R2	176	O00459
VATLAPVNSPAPQDT	MUC7	151	Q8TAX7
AALDISEPLAVSVPP	ARHGAP33	791	O14559
NDTALDPTVLSPPSL	BTBD18	236	B2RXH4
AATSLLLPIQSPEPS	DCP1B	556	Q8IZD4
TSEPLPQFVDPALVS	GATA1	11	P15976
PDIALPSQFVVPANS	HYDIN	4871	Q4G0P3
ATSLPVQDSSSVPLP	IL6R	351	P08887
PDIQVAASTFLLPPL	HEATR5A	701	Q86XA9
RPAQLPAVAPIAASS	BCL11B	146	Q9C0K0
APAAAVPTLASPLEQ	CCNDBP1	6	O95273
APALDTLPAPTSLVL	COL20A1	371	Q9P218
LILSTSQTTAPDAPP	FN1	801	P02751
IPLPANAPVAEQVSA	UPB1	81	Q9UBR1
LSFLPTEAQAQVSPP	CRTC3	431	Q6UUV7
LVSSVPTAAVPPLAN	ITSN1	146	Q15811
LAPPNIVLEDTQPFS	CENPT	231	Q96BT3
PSAPFLVSVPITLAL	CNTFR	346	P26992
ISPPDAASAAPLRTI	EPO	146	P01588
PSLAPPAVTSVVEQL	GOLGA6C	286	A6NDK9
AAVPPALLTSPQQTE	CERKL	26	Q49MI3
ADSSSALLVPPDPAQ	DGCR2	511	P98153
SIVASPEASLEAPPE	MAP7D3	381	Q8IWC1
LPAAPTVPQDVISTS	INSRR	601	P14616
AAQSLPAPLTSRADP	ARX	46	Q96QS3
NPALIEATSPVPLLA	GBF1	1831	Q92538
PSLAPPAVTSVVEQL	GOLGA6D	286	P0CG33
LLPLAPAPVFITSSQ	KLF11	366	O14901
LPVSPVTDLQATELP	COL7A1	506	Q02388
APVPQVAFSAALSLP	EMILIN1	866	Q9Y6C2
APFALPTVSLLPAIT	HDAC7	241	Q8WUI4
PESPLQSPTVLVAVL	COLGALT2	46	Q8IYK4
STALVAPVPAPDNTV	HELZ2	416	Q9BYK8
ALLTEANLPAPAPAS	BSCL2	356	Q96G97
SLPPSAVQAVLAELP	CAND2	686	O75155
ASLIPSEVPLDPTVA	DMBT1	31	Q9UGM3
LPNPVLDSISIIDTP	EHD1	141	Q9H4M9
PDVALAVSTTPAVLP	SDC3	101	O75056
PSPPSVISSIAALEN	SALL3	831	Q9BXA9
PPANIAQPVATAATD	SBNO1	171	A3KN83
PPSPINLSRSIDAAL	PRRT3	806	Q5FWE3
LDELPSTVQLLPAPT	PRRT3	931	Q5FWE3
PAEPVLINPVLADSA	PPRC1	626	Q5VV67
PAIPTPAVSSALAVA	PPP6R2	911	O75170
ASTLAPLPAPLAVAV	NPBWR1	26	P48145
TPIPARSQAPLESSL	NUMA1	1776	Q14980
PLTTALNPPVTATEE	OTOG	1516	Q6ZRI0
ALPPETPAAASLSTA	OTOG	1776	Q6ZRI0
SSLSALLSRQVPPDP	KIF17	371	Q9P2E2
VTSSVPSLPLPNVLL	GARIN1A	81	Q6NXP2
LSSPQPSEPLVLLAA	GARIN1A	211	Q6NXP2
QAQPAILVDVPDSSP	FER1L6	1151	Q2WGJ9
PLAPTVLAPRAATTL	SYNPO2L	901	Q9H987
PVQTLVSARAAAPPQ	TAF6	516	P49848
APALAQAPALSPSLA	TRMT1L	56	Q7Z2T5
QAPALSPSLASAPEE	TRMT1L	61	Q7Z2T5
VTSDPATSPLVLAIP	TRIM35	411	Q9UPQ4
AVAPSAVNLADPRTP	SRRM2	2276	Q9UQ35
AVNLADPRTPTAPAV	SRRM2	2281	Q9UQ35
NLAPDVDLTPVVPSA	PPP1R8	296	Q12972
EPTEDAAPIVSPLAS	SPATA31C2	146	B4DYI2
IPSDLTSFPAQVDLP	TMEM132D	881	Q14C87
PLIAPESFPSNLNVE	LRRN3	421	Q9H3W5
AAQLPFLSSPAVLSP	NKX1-1	416	Q15270
LLPVVLNSLTPASPT	NBPF11	791	Q86T75
SLTSILPENFPVSPE	SPATA31A6	576	Q5VVP1
AVTAPASNLAVVPPL	TDRD10	341	Q5VZ19
VSVPPASAIPAVIFA	SCRN2	16	Q96FV2
SSAVRLTPAANAPPL	GNAS	261	Q5JWF2
DTPPSALQEAAPLTS	POGZ	706	Q7Z3K3
VSLQDPPLVSPSLLA	PRR36	541	Q9H6K5
VSELSPDPPQAAAIN	EPHB6	466	O15197
LTSILPENFPVSPEL	SPATA31A7	581	Q8IWB4
SAALALAAAPAPLPQ	MEX3C	6	Q5U5Q3
SAVPLTAEEPSFLQP	RHBDF1	26	Q96CC6
TSAPVPASTLAPVLA	PRRC2C	1781	Q9Y520
AAAVAAPSVLAPTLP	SETD1B	666	Q9UPS6
VEPPRLLSSPNSASV	NPAS3	631	Q8IXF0
LAELPAPAQPSAEDS	HERC2P3	656	Q9BVR0
LTSILPENFPVSPEL	SPATA31C1	441	P0DKV0
ASAPLTIPISAPLTV	SRCAP	1451	Q6ZRS2
APASVQTLTLSPAPV	SRCAP	1781	Q6ZRS2
FTIPNSPLALPADLV	NPAP1	456	Q9NZP6
PSVLAVSVPAPTNVL	TGIF2	111	Q9GZN2
PALQDLSLTLIASPP	ACD	256	Q96AP0
DIVINANPASPPLSL	AIMP2	121	Q13155
SFVASDVPNAPIPDL	CLCA1	736	A8K7I4
SQPDPVSADALLTLP	C11orf53	116	Q8IXP5
SLALASEEQPPELPS	INPP5J	186	Q15735
LTSILPENFPVSPEL	SPATA31A3	581	Q5VYP0
ASAAVLSSPPRAPLQ	ZNF532	411	Q9HCE3
RQASPVAPLLAAPTA	nan	11	Q6ZSR3
ITESQSSPPPVIDLI	VPS13A	1246	Q96RL7
SLLPLLSSAVEPPDQ	VEZF1	26	Q14119
VAEAPPAASSLSLPV	MKRN3	156	Q13064
LTSILPENFPVSPEL	SPATA31A1	581	Q5TZJ5
APQVCPLPLNSTTEA	SEC16A	671	O15027
AALPPTLSRTPEVQS	SPTBN2	811	O15020
LTSILPENFPVSPEL	SPATA31A5	581	Q5VU36
VLPPIPANSFQLESD	RPAP3	541	Q9H6T3
IPLTSAASAITPPNV	SH3RF3	666	Q8TEJ3
SLPASQPPVAVAEQV	SP2	251	Q02086
VIPFLPLESSPAQLS	TICAM1	486	Q8IUC6
PPLATNTVSPSLALL	SAP130	801	Q9H0E3
PEVAPALSPDALSIS	TANGO6	126	Q9C0B7
TIVDPENPPATAFLT	SH2D7	161	A6NKC9
ANTPSSELVALTPAP	PHC1	691	P78364
SPPVAFTEVLQAPAI	PPP1R3F	401	Q6ZSY5
IQPAAPADLESPTLA	TACC2	1866	O95359
PPLTPVLTAFLETQA	SIGLEC1	411	Q9BZZ2
DLTNDVSSLDPTLPP	SNX19	486	Q92543
AILPQDISVTPVATP	SMO	631	Q99835
AALPLAAEETANLPP	MAP2	121	P11137
ASSPVPATPILQLEE	TRIM9	436	Q9C026
PLSESQTLLSSAPVP	YY1AP1	541	Q9H869
LVNIPPAVSDSDSSP	TJP3	276	O95049
VLLSPEAVAATTPVP	RELT	306	Q969Z4
EAVAATTPVPSLLPN	RELT	311	Q969Z4
VFIESIQPPSISAPA	ZMYM5	61	Q9UJ78
IQPPSISAPAIADQR	ZMYM5	66	Q9UJ78
ELEASSPVLPFSIIP	TTC7A	841	Q9ULT0
AAPELLPQFPSSLAT	WNK2	1061	Q9Y3S1
IALDAEPVTQPASLP	WDCP	511	Q9H6R7
SNPVLLEAPVDSSPL	HIVEP2	526	P31629
PPLAPVVSTSTALQQ	TRIM66	811	O15016
AVDSVTIPPAPVLSL	SETBP1	1366	Q9Y6X0
TIPPAPVLSLLAASA	SETBP1	1371	Q9Y6X0
PETLADIPASPQLLT	UPK3B	141	Q9BT76
APQPSTVVPVLLELS	VWA7	716	Q9Y334
LPSIPAQPISADIAS	TFR2	351	Q9UP52
SALEPSVPVLEPAVS	SON	1411	P18583
SVPVLEPAVSVLQPS	SON	1416	P18583
SIEPPALSPSIVVNS	TOX4	331	O94842
PAPSAVPALDSVRQA	WDR81	166	Q562E7
PAALSSPLAVPALSA	ZNF692	246	Q9BU19
LPAAPVETQAPAILA	ZDHHC1	231	Q8WTX9
SAPAQLPAALVDPQL	nan	61	Q6ZQT7
PPVVPELFLAAAETT	ZNF628	276	Q5EBL2
ITPTVAAFPLESADP	NACA	641	E9PAV3
APSPQNTCAPLATLV	NACA	711	E9PAV3
PLPQLLPSVTDARSA	N4BP1	566	O75113
ESPPSLAAPLASIFQ	EXD3	116	Q8N9H8
PVAFLSSVLPSLPAI	MYPN	826	Q86TC9